var title_f38_49_39696="Tobramycin: Patient drug information";
var content_f38_49_39696=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tobramycin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block note\" id=\"F12804745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12804746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/31/25076?source=see_link\">",
"       Tobramycin (ophthalmic): Patient drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/45/15061?source=see_link\">",
"       Tobramycin (systemic therapy and oral inhalation): Patient drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11887 Version 25.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.66.252.144-2A34E2F131-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39696=[""].join("\n");
var outline_f38_49_39696=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?24/31/25076?source=related_link\">",
"      Tobramycin (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/45/15061?source=related_link\">",
"      Tobramycin (systemic therapy and oral inhalation): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_49_39697="Tonsillectomy technique";
var content_f38_49_39697=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    Tonsillectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 502px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An Allis clamp is used to grasp the upper portion of the tonsil. As it is pulled anteriorly and medially, the anterior tonsillar pillar mucosa is divided superiorly to inferiorly. With the superior pole of the tonsil freed, the Allis clamp can be repositioned as needed to grasp the inferior tonsil and the tonsil dissected out of its bed. Control of perforating vessels is performed as they are encountered.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39697=[""].join("\n");
var outline_f38_49_39697=null;
var title_f38_49_39698="Ultrasound of incarcerated uterus";
var content_f38_49_39698=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83558&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Ultrasound of incarcerated uterus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 465px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transabdominal ultrasound image at 18 weeks of gestation shows an incarcerated uterus. The cervix is stretched anteriorly (arrows), and the uterine fundus is posterior to the cervix. Note fetal head (H) and free fluid in the cul-de-sac (ff).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39698=[""].join("\n");
var outline_f38_49_39698=null;
var title_f38_49_39699="Synostosis variations";
var content_f38_49_39699=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F52793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F52793&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 503px\">",
"   <div class=\"ttl\">",
"    Common variation in craniosynostosis presentations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 483px; height: 535px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note that deformational plagiocephaly is caused by positional deformation, and is often correctable without surgical intervention.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39699=[""].join("\n");
var outline_f38_49_39699=null;
var title_f38_49_39700="Polysaccharide-iron complex: Patient drug information";
var content_f38_49_39700=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Polysaccharide-iron complex: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29572?source=see_link\">",
"     see \"Polysaccharide-iron complex: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F211213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ferrex&trade; 150 Plus [OTC];",
"     </li>",
"     <li>",
"      Ferrex&trade; 150 [OTC];",
"     </li>",
"     <li>",
"      Nu-Iron&reg; 150 [OTC];",
"     </li>",
"     <li>",
"      Poly-Iron 150 [OTC];",
"     </li>",
"     <li>",
"      ProFe [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10113280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Accidental overdose of drugs that have iron in them is a leading cause of deadly poisoning in children younger than 6 years of age. Keep away from children. If this drug is taken by accident, call a doctor or poison control center right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10113284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691725",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Iron is most often taken during pregnancy to stop anemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10113282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702758",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to polysaccharide-iron complex or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703226",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Anemia from a cause other than low iron stores, too much iron in your body, or thalassemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10113292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696857",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take calcium, zinc, copper, or multivitamins that have any of these minerals within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take tetracycline within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take antibiotics like ciprofloxacin and levofloxacin 2 hours before this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10113294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black stools.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10113298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3546302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If a child eats your capsules. Poisonings with iron happen most often in children. First signs of overdose include feeling tired, upset stomach, throwing up, belly pain, dark tarry-black stool, and a weak or fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, period changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10113288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695812",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 1 hour before or 2 hours after bran, fiber, tea, coffee, dairy products, or eggs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694866",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10113290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10113300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10113302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11833 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-9089A68DA0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39700=[""].join("\n");
var outline_f38_49_39700=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F211213\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113280\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113284\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113282\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113292\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113294\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113298\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113288\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113290\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113300\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10113302\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29572?source=related_link\">",
"      Polysaccharide-iron complex: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_49_39701="Perindopril and indapamide: Patient drug information";
var content_f38_49_39701=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Perindopril and indapamide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/24/34183?source=see_link\">",
"     see \"Perindopril and indapamide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5176506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Coversyl&reg; Plus;",
"     </li>",
"     <li>",
"      Coversyl&reg; Plus HD;",
"     </li>",
"     <li>",
"      Coversyl&reg; Plus LD",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702718",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to perindopril erbumine, indapamide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3431182",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Low potassium levels, very bad kidney disease, or very bad liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698524",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), you will need to watch your blood sugar closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696843",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids, iron, or multivitamins that have iron with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11996 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-197.136.42.3-1F4CD360AE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39701=[""].join("\n");
var outline_f38_49_39701=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5176506\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020939\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020941\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020940\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020945\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020946\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020948\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020943\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020944\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020949\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020950\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?33/24/34183?source=related_link\">",
"      Perindopril and indapamide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_49_39702="Prognosis of nonsustained VT in the presence of structural heart disease";
var content_f38_49_39702=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prognosis of nonsustained VT in the presence of structural heart disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     Mark E Josephson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     John V Wylie, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     Mark S Link, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39702/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/49/39702/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsustained ventricular tachycardia (NSVT) is an extremely common but poorly understood arrhythmia. It is usually asymptomatic and most often diagnosed on ambulatory monitoring, telemetry, or on an exercise test performed for other reasons.",
"   </p>",
"   <p>",
"    The presence of NSVT has long been recognized as a potential marker for the development of sustained ventricular arrhythmias and sudden death. Unfortunately, our understanding of which patients with NSVT are at greatest risk for lethal arrhythmias is still quite rudimentary. One clearly established premise is that NSVT in the presence of structural heart disease carries a more serious prognosis than NSVT in the absence of a myocardial abnormality. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/41/13974?source=see_link\">",
"     \"Nonsustained VT in the absence of apparent structural heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review important definitions that pertain to NSVT as well as the prognosis and evaluation of this arrhythmia in various clinical settings associated with underlying heart disease. The management of patients with NSVT is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/26/22952?source=see_link\">",
"     \"Management of nonsustained ventricular tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;We define NSVT as three or more consecutive ventricular beats at a rate of greater than 120",
"    <span class=\"nowrap\">",
"     beats/min",
"    </span>",
"    with a duration of less than 30 seconds. There is, however, great variability in the literature in the definition of this arrhythmia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/1\">",
"     1",
"    </a>",
"    ]. Some definitions allow a rate as low as 100",
"    <span class=\"nowrap\">",
"     beats/min",
"    </span>",
"    or as high as 140",
"    <span class=\"nowrap\">",
"     beats/min;",
"    </span>",
"    others require five complexes, limit NSVT to fewer than 15 beats or to as many as 99 beats, and vary the duration from as short as 15 seconds or as high as one minute.",
"   </p>",
"   <p>",
"    The significance of NSVT is related to the characteristics of the myocardium in which it occurs. Structural anatomic abnormalities in the heart are believed to serve as a substrate for the genesis of arrhythmias. Structural heart disease can be further defined in clinical terms as:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Myocardial scar from a prior myocardial infarction (coronary heart disease)",
"     </li>",
"     <li>",
"      Hypertrophy (as with hypertrophic obstructive cardiomyopathy)",
"     </li>",
"     <li>",
"      Dilated cardiomyopathy",
"     </li>",
"     <li>",
"      Valvular heart disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of NSVT depends upon whether it is associated with structural heart disease. The data presented below represent our current understanding of the relative risks of NSVT in patients with different forms of structural heart disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Coronary heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The significance of NSVT following a myocardial infarction is dependent upon the proximity of the arrhythmia to the time of the infarction. NSVT commonly occurs within the first 24 to 48 hours; early NSVT is probably related to ischemia or reperfusion in this setting and is generally considered no prognostic significance. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/24/20874?source=see_link&amp;anchor=H11#H11\">",
"     \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\", section on 'NSVT on monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, data from many sources including the Multicenter Postinfarction Research Group has found that NSVT detected at one week or later post-MI carries at least a two-fold increase in the risk of sudden cardiac death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Nonsustained ventricular tachycardia as well as sustained ventricular arrhythmias that occur after the acute MI period are believed to result from the formation of scar tissue.",
"   </p>",
"   <p>",
"    The risk of NSVT is even further increased in post-MI patients with significantly diminished left ventricular function (left ventricular ejection fraction less than 40 percent). In this setting, the risk of sudden death is increased more than five-fold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Independent of left ventricular function, the risk of sudden death is greatest in the first six months post-MI and persists for up to two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Finally, NSVT that is first detected more than one year post-MI carries a two-fold increase in the risk of sudden death, particularly when associated with clinical evidence of left ventricular dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An important therapeutic issue is the absolute, rather than relative, risk imposed by NSVT after MI. Despite the compelling evidence for the association of Holter-identified NSVT with enhanced relative risk, the absolute risk for an individual patient is only about 14 percent during his or her lifetime [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/26/22952?source=see_link\">",
"     \"Management of nonsustained ventricular tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hypertrophic cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies using ambulatory electrocardiographic monitoring have shown that approximately 25 percent of patients with hypertrophic cardiomyopathy (HCM) have short runs of asymptomatic NSVT. The presence of NSVT is associated with an increased risk of sudden cardiac death, which may be primarily limited to patients with episodes that are prolonged, repetitive, or associated with symptoms of impaired consciousness. This issue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/3/22586?source=see_link\">",
"     \"Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Idiopathic dilated cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSVT is common in patients with idiopathic dilated cardiomyopathy (IDCM), occurring in up to 80 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. A composite analysis of the major studies evaluating the importance of NSVT in IDCM found it to be an insensitive and nonspecific predictor of sudden death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/6\">",
"     6",
"    </a>",
"    ]. In a report from the CHF-STAT trial of 674 patients with heart failure receiving vasodilator therapy, all-cause and sudden death mortalities were higher among patients with NSVT, especially when persistently present during the 45 month follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/7\">",
"     7",
"    </a>",
"    ]. However, after adjusting for other variables, only the left ventricular ejection fraction (LVEF) and NYHA class, but not NSVT (regardless of length or rate), were independent predictors of mortality.",
"   </p>",
"   <p>",
"    Data from the PROMISE study of 1080 patients with class III and IV heart failure support those from CHF-STAT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/8\">",
"     8",
"    </a>",
"    ]. Although the frequency of NSVT was a significant independent predictor of both sudden and nonsudden death mortality, multiple logistic analysis found that NSVT did not specifically define a group at high risk for sudden death and did not provide incremental prognostic information beyond that from readily available clinical variables. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/47/21241?source=see_link&amp;anchor=H25#H25\">",
"     \"Ventricular arrhythmias in heart failure and cardiomyopathy\", section on 'Nonsustained VT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Valvular heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral and aortic valvular disease are often associated with NSVT. This is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NSVT is seen in up to 20 percent of patients with mitral valve prolapse. It does not, however, appear to confer an increased risk for sudden death in these patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/19/17719?source=see_link\">",
"       \"Arrhythmic complications of mitral valve prolapse\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The frequency of NSVT is increased in patients with significant mitral regurgitation. However, two year follow-up data in patients with severe mitral regurgitation, regardless of cause, found left ventricular function, not NSVT or the etiology of valvular disease, to be the most important prognostic factor for sudden death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      NSVT and ventricular premature beats are common in patients with aortic stenosis. Sudden death has been observed in 0 to 5 percent of adults with asymptomatic aortic stenosis and in 8 to 34 percent with symptomatic aortic stenosis. A relationship between NSVT and sudden death has not been established. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=see_link&amp;anchor=H21#H21\">",
"       \"Clinical features and evaluation of aortic stenosis in adults\", section on 'Other clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ELECTROPHYSIOLOGIC STUDY AND SIGNAL-AVERAGED ELECTROCARDIOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrophysiologic testing (EPS) and signal averaged electrocardiography (SAECG) are two tools that have been used in patients with NSVT in an attempt to identify those at greatest risk of fatal arrhythmias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Electrophysiologic study",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrophysiologic testing involves the introduction of electrical impulses (extrastimuli) into the ventricle following a train of eight to 10 paced ventricular complexes. The likelihood of inducing a ventricular arrhythmia increases with increasing numbers of extrastimuli and with impaired ventricular function.",
"   </p>",
"   <p>",
"    Studies using aggressive protocols which include three extrastimuli report the induction of sustained monomorphic VT (SMVT) in 20 to 40 percent of patients with coronary heart disease and NSVT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/11\">",
"     11",
"    </a>",
"    ]. The incidence increases to 50 percent when significant left ventricular dysfunction is also present. However, other clinical variables are of limited value for predicting the patient with NSVT and left ventricular function who will have inducible SMVT. In the MUSTT trial, for example, the rate of inducibility was higher in patients with a history of a myocardial infarction, higher in men, and progressively higher with an increasing number of diseased coronary arteries and number of fixed thallium defects; it was lower in those with prior bypass surgery and with noncoronary cardiac disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/12\">",
"     12",
"    </a>",
"    ]. While these associations were statistically significant, the accuracy for discriminating patients with and without inducible SMVT was only modest.",
"   </p>",
"   <p>",
"    The negative predictive value of EPS for sudden death is approximately 92 percent over at least five to ten years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/5\">",
"     5",
"    </a>",
"    ]. Although the positive predictive value of EPS is not certain, the MUSTT trial found that, among patients with NSVT who have SMVT induced and are untreated, the two and five year rates of arrhythmic death or resuscitated sudden death were 18 and 32 percent, respectively (",
"    <a class=\"graphic graphic_figure graphicRef68247 \" href=\"mobipreview.htm?1/34/1582\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/13\">",
"     13",
"    </a>",
"    ]. In contrast, the rate was 12 and 24 percent, respectively, among those who did not have SMVT induced (p&lt;0.001) (",
"    <a class=\"graphic graphic_figure graphicRef80519 \" href=\"mobipreview.htm?7/20/7502\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/14\">",
"     14",
"    </a>",
"    ]. The overall mortality at five years in those with and without inducible SMVT was 48 and 44 percent, respectively (p = 0.005), and death among those without inducible SMVT was less likely to be arrhythmic (45 versus 54 percent in those with inducible SMVT). Results were similar in another study of 93 patients with NSVT on Holter who did not have inducible SMVT; although the overall mortality was high, especially in those with an LVEF &le;35 percent (15 and 34 percent at one and three years), the sudden death mortality was only 4 and 18 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another analysis from the MUSTT trial suggested that the utility of EPS in risk stratification for arrhythmic death is influenced by the LVEF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/16\">",
"     16",
"    </a>",
"    ]. The rate of arrhythmic death at five years was not significantly increased if VT was inducible when the LVEF was below 30 percent (40 versus 31 percent) but was significantly increased at higher ejection fractions (30 versus 17 percent). It was suggested by the authors that for patients with ejection fractions &ge;30 percent only, EP testing may have useful predictive value. However, the magnitude of the difference in risk for the two groups was similar (9 percent for LVEF &lt;30 percent, 13 percent for LVEF &ge;30 percent), suggesting that the perceived difference in the utility of EP testing may have resulted from a beta error (ie, the study was underpowered). A second limitation is that 76 percent of the patients in MUSTT were not inducible on EP testing; thus, this technique at best identifies only a minority of those at risk for sudden death. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/24/20874?source=see_link\">",
"     \"Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with coronary disease, the degree of QT dispersion can help to predict the likelihood of induction of sustained VT. As an example, one study evaluated the association between QT dispersion and induction of VT among 35 patients. Compared to those unable to be induced, QT dispersion was significantly greater in those with inducible VT (126 versus 67 msec) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/17\">",
"     17",
"    </a>",
"    ]. Furthermore, all patients with a QT dispersion &gt;120 msec had inducible VT, while VT was not induced in any patient with a QT dispersion &lt;90 msec (",
"    <a class=\"graphic graphic_figure graphicRef54411 \" href=\"mobipreview.htm?10/21/10589\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/51/26425?source=see_link\">",
"     \"QT dispersion: Measurement and interpretation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/33/10778?source=see_link\">",
"     \"QT dispersion: Clinical applications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    EPS in patients with HOCM has been shown to induce polymorphic VT in up to 50 percent of patients. However, the significance of this end point is of unclear prognostic importance, since there are currently no prospective controlled trials evaluating EPS in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EPS appears to be a nonspecific and insensitive tool for patients with idiopathic dilated cardiomyopathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/12\">",
"     12",
"    </a>",
"    ]. Ventricular arrhythmias, both monomorphic and polymorphic, are commonly induced but do not predict a greater likelihood for sudden death compared with patients without inducible VT. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/47/21241?source=see_link\">",
"     \"Ventricular arrhythmias in heart failure and cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Signal-averaged ECG",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signal averaging is a method that employs filtering and averaging of the QRS complex in order to identify very low amplitude cardiac potentials. In particular, this technique allows the identification of late ventricular potentials that are believed to represent delayed and disordered ventricular conduction. These late potentials have been found in up to 5 percent of the normal population, but are substantially more common in patients with structural heart disease, particularly those with coronary disease who have had a prior large myocardial infarction, and in patients with arrhythmic right ventricular cardiomyopathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27544?source=see_link\">",
"     \"Use of the signal-averaged electrocardiogram in ischemic heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Chronic coronary heart disease/left ventricular dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of the SAECG in patients with coronary heart disease and left ventricular dysfunction who had asymptomatic NSVT was assessed in 1925 patients in the MUSTT trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/19\">",
"     19",
"    </a>",
"    ]. A filtered QRS duration &gt;114 ms was an independent predictor of the five year rate of arrhythmic death or cardiac arrest (28 versus 17 percent with QRS &le;114 ms), cardiac death (37 versus 25 percent), and total mortality (43 versus 35 percent). The combination of an LVEF &lt;30 percent and a QRS duration &gt;114 ms, which was present in 21 percent of the population, was associated with the highest incidence of arrhythmic and cardiac deaths (36 and 44 percent, respectively) (",
"    <a class=\"graphic graphic_figure graphicRef66009 \" href=\"mobipreview.htm?24/7/24702\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Postmyocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have shown that the SAECG correlates with the development of postinfarction VT and sudden death. Up to 40 percent of post-MI patients have positive SAECG but the positive predictive value for the development of sustained VT or sudden death is only 15 to 30 percent. The negative predictive value in post-MI patients is substantially better, being higher than 90 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39702/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27544?source=see_link\">",
"     \"Use of the signal-averaged electrocardiogram in ischemic heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;SAECG does not appear to have a role in the evaluation of NSVT in patients with hypertrophic cardiomyopathy or idiopathic cardiomyopathy. The data are not substantial enough to review at this time. The use of SAECG in the evaluation of arrhythmogenic right ventricular cardiomyopathy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36661?source=see_link\">",
"     \"Use of the signal-averaged electrocardiogram in nonischemic heart disease and cardiac transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      NSVT in the presence of structural heart disease, particularly coronary heart disease and perhaps hypertrophic cardiomyopathy, is associated with an increased risk for sudden death. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A low ejection fraction in patients with coronary disease is an additive risk factor and is at least as potent predictor of sudden cardiac death as NSVT. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Coronary heart disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      However, the absolute number of patients who will have sudden death is small (about 14 percent) compared with the number of patients with NSVT. Furthermore, our ability to predict which individuals with NSVT and structural heart disease are at greatest risk for sudden death on the basis of Holter monitoring alone is poor. As a result, additional tools are being evaluated in an attempt to enhance prognostic accuracy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The efficacy of EPS and SAECG in the evaluation of NSVT is still unclear, although data from MUSTT support their usefulness in patients with coronary heart disease and an ejection fraction less than 40 percent. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Electrophysiologic study and signal-averaged electrocardiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The management of patients with NSVT is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/26/22952?source=see_link\">",
"       \"Management of nonsustained ventricular tachycardia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/1\">",
"      Anderson KP, DeCamilla J, Moss AJ. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation 1978; 57:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/2\">",
"      Bigger JT Jr, Fleiss JL, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol 1986; 58:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/3\">",
"      Mukharji J, Rude RE, Poole WK, et al. Risk factors for sudden death after acute myocardial infarction: two-year follow-up. Am J Cardiol 1984; 54:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/4\">",
"      Buxton AE, Marchlinski FE, Waxman HL, et al. Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol 1984; 53:1275.",
"     </a>",
"    </li>",
"    <li>",
"     Buxton AE. Patients with nonsustained ventricular tachycardia. In: Sudden Cardiac Death: Prevalence, Mechanisms, and Approach to Diagnosis and Management, Akhtar M, Myerburg R, Ruskin J (Eds), Williams &amp; Wilkins, Baltimore 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/6\">",
"      Larsen L, Markham J, Haffajee CI. Sudden death in idiopathic dilated cardiomyopathy: role of ventricular arrhythmias. Pacing Clin Electrophysiol 1993; 16:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/7\">",
"      Singh SN, Fisher SG, Carson PE, Fletcher RD. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol 1998; 32:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/8\">",
"      Teerlink JR, Jalaluddin M, Anderson S, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 2000; 101:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/9\">",
"      Kligfield P, Levy D, Devereux RB, Savage DD. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987; 113:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/10\">",
"      Kligfield P, Hochreiter C, Niles N, et al. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. Am J Cardiol 1987; 60:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/11\">",
"      Wilber DJ, Kopp D, Olshansky B, et al. Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: implications for prophylactic automatic implantable cardioverter-defibrillator use. Prog Cardiovasc Dis 1993; 36:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/12\">",
"      Buxton AE, Hafley GE, Lehmann MH, et al. Prediction of sustained ventricular tachycardia inducible by programmed stimulation in patients with coronary artery disease. Utility of clinical variables. Circulation 1999; 99:1843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/13\">",
"      Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341:1882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/14\">",
"      Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000; 342:1937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/15\">",
"      Schmitt H, Hurst T, Coch M, et al. Nonsustained, asymptomatic ventricular tachycardia in patients with coronary artery disease: prognosis and incidence of sudden death of patients who are noninducible by electrophysiological testing. Pacing Clin Electrophysiol 2000; 23:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/16\">",
"      Buxton AE, Lee KL, Hafley GE, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002; 106:2466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/17\">",
"      Bogun F, Chan KK, Harvey M, et al. QT dispersion in nonsustained ventricular tachycardia and coronary artery disease. Am J Cardiol 1996; 77:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/18\">",
"      McKenna WJ. The natural history of hypertrophic cardiomyopathy. Cardiovasc Clin 1988; 19:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39702/abstract/19\">",
"      Gomes JA, Cain ME, Buxton AE, et al. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001; 104:436.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 942 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-C008A65255-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39702=[""].join("\n");
var outline_f38_49_39702=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Idiopathic dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Valvular heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ELECTROPHYSIOLOGIC STUDY AND SIGNAL-AVERAGED ELECTROCARDIOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Electrophysiologic study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Signal-averaged ECG",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Chronic coronary heart disease/left ventricular dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Postmyocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/942\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/942|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/34/1582\" title=\"figure 1\">",
"      ICD vs no ICD MUSTT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/20/7502\" title=\"figure 2\">",
"      Outcome with inducible VT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/21/10589\" title=\"figure 3\">",
"      QTd and inducible VT post MI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/7/24702\" title=\"figure 4\">",
"      Positive SAECG predicts outcomes with NSVT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/19/17719?source=related_link\">",
"      Arrhythmic complications of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/22/32106?source=related_link\">",
"      Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/24/20874?source=related_link\">",
"      Incidence of and risk stratification for sudden cardiac death after acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/26/22952?source=related_link\">",
"      Management of nonsustained ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/41/13974?source=related_link\">",
"      Nonsustained VT in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/33/10778?source=related_link\">",
"      QT dispersion: Clinical applications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/51/26425?source=related_link\">",
"      QT dispersion: Measurement and interpretation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/57/27544?source=related_link\">",
"      Use of the signal-averaged electrocardiogram in ischemic heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/51/36661?source=related_link\">",
"      Use of the signal-averaged electrocardiogram in nonischemic heart disease and cardiac transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/3/22586?source=related_link\">",
"      Ventricular arrhythmias and sudden cardiac arrest in hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/47/21241?source=related_link\">",
"      Ventricular arrhythmias in heart failure and cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_49_39703="XRT variable dose neck";
var content_f38_49_39703=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F58544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F58544&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    External radiation therapy for thyroid cancer: Variable dose to the neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 443px; height: 430px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radiation treatment plan for a 47-year-old woman who presented with locally advanced medullary thyroid cancer involving the left recurrent nerve and with esophageal and tracheal invasion. She had bilateral neck dissection: 4 out of 24 nodes were involved on the right and 20 out of 23 on the left with extracapsular invasion. Intensity modulate radiation therapy (IMRT) allows for giving variable dose to the neck depending on the risk of recurrence, while sparing as much normal tissue as possible. The red shaded area represents the volume where there was gross disease before surgery; orange represents the area of potential residual disease; the blue and green shaded area represents the volume of potential residual nodal disease. The volume of tissue within each line (isodose line) receives a minimum dose represented by that line. The yellow line is the 66Gy isodose line (eg, the orange and red volumes within that line receive a minimum of 66Gy). The mauve line is the 53.2Gy isodose line (blue and green volumes receive a minimum of 53.4Gy).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James D Brierley, MB, BS, FRCP, FRCR, FRCPC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39703=[""].join("\n");
var outline_f38_49_39703=null;
var title_f38_49_39704="Evaluation of the adult with headache in the emergency department";
var content_f38_49_39704=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the adult with headache in the emergency department",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     F Michael Cutrer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     Jerry W Swanson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     Robert S Hockberger, MD, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39704/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/49/39704/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with headache constitute up to 4.5 percent of emergency department visits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The differentiation of the small number of patients with life-threatening headaches from the overwhelming majority with benign primary headaches (ie, migraine, tension, or cluster) is an important problem in the emergency department. Failure to recognize a serious headache can have potentially fatal consequences.",
"   </p>",
"   <p>",
"    A careful history and physical examination remain the most important part of the assessment of the headache patient; they enable the clinician to determine whether the patient is at significant risk for a dangerous cause of their symptoms and what additional workup is necessary.",
"   </p>",
"   <p>",
"    This topic will discuss how to approach adults presenting with headache in the emergency department with an emphasis on those components of the history and physical examination that characterize high-risk headaches. A flow chart to help guide this evaluation is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef71604 graphicRef51917 \" href=\"mobipreview.htm?25/39/26230\">",
"     algorithm 1A-B",
"    </a>",
"    ). Detailed discussions of specific causes of headache are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32953?source=see_link\">",
"     \"Headache, migraine, and stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/44/21194?source=see_link\">",
"     \"Acute treatment of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42889?source=see_link\">",
"     \"Preventive treatment of migraine in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HIGH-RISK HISTORICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The essential job of the emergency clinician is to determine which patients are at high-risk for a dangerous underlying cause of their headache. Such headaches are commonly referred to as secondary to distinguish them from benign intrinsic causes (ie, migraine, cluster, and tension), which are referred to as primary. The following historical features are warning signs to the presence of a secondary headache (",
"    <a class=\"graphic graphic_table graphicRef78567 \" href=\"mobipreview.htm?11/55/12155\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Sudden onset",
"    </span>",
"    &nbsp;&mdash;&nbsp;A severe persistent headache that reaches maximal intensity within a few",
"    <strong>",
"     seconds",
"    </strong>",
"    or",
"    <strong>",
"     minutes",
"    </strong>",
"    after the onset of pain warrants aggressive investigation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Subarachnoid hemorrhage (SAH), for example, often presents with the abrupt onset of excruciating pain. Other serious etiologies of sudden-onset headache include carotid and vertebral artery dissections, venous sinus thrombosis, pituitary apoplexy, acute angle-closure glaucoma, and hypertensive emergencies (",
"    <a class=\"graphic graphic_table graphicRef61027 \" href=\"mobipreview.htm?27/16/27915\">",
"     table 2",
"    </a>",
"    ). In contrast, migraine headaches generally begin with mild to moderate pain and then gradually increase to a maximal level over one to two hours.",
"   </p>",
"   <p>",
"    Cluster headache may sometimes be confused with a serious headache, since the pain from a cluster headache can reach full intensity within minutes. However, cluster headache is transient (usually lasting less than one to two hours) and is associated with characteristic ipsilateral autonomic signs, such as tearing or rhinorrhea. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14327?source=see_link\">",
"     \"Cluster headache: Epidemiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of note, pain may increase gradually with some dangerous causes of headache, such as herpetic or Lyme meningitis and idiopathic intracranial hypertension. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     No similar headaches in the past",
"    </span>",
"    &nbsp;&mdash;&nbsp;The absence of similar headaches in the past is another finding that suggests a serious disorder. The \"first\" or \"worst headache of my life\" is a description that sometimes accompanies an intracranial hemorrhage or central nervous system (CNS) infection. A new or unusual headache in a patient with AIDS or cancer is particularly worrisome, as it suggests an intracranial lesion or infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/6\">",
"     6",
"    </a>",
"    ]. On the other hand, patients suffering from migraine usually have had similar headaches in the past. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'HIV and immunosuppression'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Concomitant infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection in a nonintracranial location (such as the lungs or the paranasal or mastoid sinuses) may serve as a nidus for the development of meningitis or intracranial abscess. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of brain abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Altered mental status or seizure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any change in mental status, personality, or fluctuation in the level of consciousness suggests a potentially serious abnormality. Syncope or near syncope is suggestive of SAH. Headache associated with seizure is also concerning for intracranial pathology. Preeclampsia can cause a headache and may present following delivery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=see_link\">",
"     \"Stupor and coma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=see_link\">",
"     \"Preeclampsia: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Headache with exertion",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rapid onset of headache with exertion (eg, sexual intercourse, exercise), especially when minor trauma has occurred, raises the possibility of carotid artery dissection or intracranial hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32953?source=see_link\">",
"     \"Headache, migraine, and stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44356?source=see_link\">",
"     \"Primary exertional headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Age over 50",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients over 50 years of age with new onset or progressively worsening headache are at significantly greater risk of a dangerous cause of their symptoms, including an intracranial mass lesion and temporal arteritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/1,4,7\">",
"     1,4,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/33/18969?source=see_link\">",
"     \"Clinical manifestations of giant cell (temporal) arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     HIV and immunosuppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV and other immunosuppressed patients with headache are at significant risk for intracranial disease, including toxoplasmosis, stroke, brain abscess, meningitis, and malignancy of the central nervous system. Clinicians should have a low threshold to perform aggressive workups on such patients, particularly if high-risk features such as new-onset seizure or altered mental status is present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41128?source=see_link\">",
"     \"Approach to HIV-infected patients with central nervous system lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Visual disturbances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally patients with significant ophthalmologic disease, most notably acute narrow angle glaucoma (ANAG), will present with a complaint of headache. A careful history and physical examination, including measurement of intraocular pressures when warranted, is usually sufficient to determine whether this is the source of pain. Headache associated with visual disturbances may also be associated with giant cell arteritis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/54/9063?source=see_link&amp;anchor=H9#H9\">",
"     \"Angle-closure glaucoma\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/33/18969?source=see_link\">",
"     \"Clinical manifestations of giant cell (temporal) arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Location of pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head pain that spreads into the lower neck (ie, occipitonuchal headache) and between the shoulders may indicate meningeal irritation due to either infection or subarachnoid blood; it is not typical of a benign process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/1\">",
"     1",
"    </a>",
"    ]. Some secondary headaches are well localized. As an example, headache from acute narrow angle glaucoma is commonly centered around the involved eye, while headache from temporal arteritis, as implied by its name, can be focused in a temple, although not always. Generally, however, headache location is nonspecific and should not be relied upon for diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The headache patient with a family history of subarachnoid hemorrhage (SAH) among first or second-degree relatives is at significantly greater risk of SAH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link&amp;anchor=H7#H7\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Genetic risk'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians should inquire about medication use, particularly anticoagulants, glucocorticoids, and analgesics. Use of anticoagulants or nonsteroidal anti-inflammatory drugs, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , increases the risk of intracranial bleeding. Sympathomimetics are also associated with intracranial bleeding. Analgesics can mask severe symptoms or sometimes exacerbate migraine headache through a rebound effect (medication overuse headache). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/44/21194?source=see_link\">",
"     \"Acute treatment of migraine in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6723177\">",
"    <span class=\"h2\">",
"     Illicit drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of illicit drugs, including cocaine, methamphetamine, and other sympathomimetic agents, increase the risk of stroke and intracranial bleeding. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/39/39545?source=see_link&amp;anchor=H10#H10\">",
"     \"Evaluation and management of the cardiovascular complications of cocaine abuse\", section on 'Stroke'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4699896\">",
"    <span class=\"h2\">",
"     Toxic exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Headaches that involve multiple family members or coworkers and improve rapidly in the emergency department without intervention, particularly during winter months, raise the possibility of carbon monoxide poisoning. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/6/10345?source=see_link\">",
"     \"Carbon monoxide poisoning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Additional history",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other historical factors to consider when investigating the cause of headache include head trauma, possible toxic exposures (eg, carbon monoxide), and comorbidities known to put patients at higher-risk for critical secondary causes of headache. Such comorbidities include malignancy with a risk of intracranial metastasis and polycystic kidney disease or connective tissue disease, both of which increase the risk of aneurysms with resultant SAH. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link\">",
"     \"Management of acute severe traumatic brain injury\"",
"    </a>",
"    .) Jaw claudication suggests temporal arteritis as the cause of headache. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/33/18969?source=see_link\">",
"     \"Clinical manifestations of giant cell (temporal) arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Comorbidities that adversely affect coagulation increase the risk of headache from dangerous causes. As examples, liver disease or clotting disorders may predispose patients to intracranial bleeding, while hypercoagulable states may increase the risk of stroke or cerebral venous thrombosis. Some regions may have high rates of particular infections that may present with headache as a prominent symptom (eg, Lyme disease). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35225?source=see_link\">",
"     \"Clinical manifestations of Lyme disease in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7594?source=see_link\">",
"     \"Etiology, clinical features, and diagnosis of cerebral venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several less common headache syndromes associated with specific symptoms or signs may be associated with dangerous underlying etiologies. As examples, headache induced by cough or valsalva may be caused by malignancy or cerebrovascular disease, and headache associated with positional hypotension may be caused by leaking cerebrospinal fluid (CSF). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/37/22101?source=see_link\">",
"     \"Primary cough headache\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/20/330?source=see_link\">",
"     \"Pathophysiology, clinical features, and diagnosis of spontaneous low cerebrospinal fluid pressure headache\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     HIGH-RISK EXAMINATION FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following findings on physical examination may suggest a life-threatening cause of headache (",
"    <a class=\"graphic graphic_table graphicRef78567 \" href=\"mobipreview.htm?11/55/12155\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38377?source=see_link\">",
"     \"The detailed neurologic examination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Neurologic abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with any new focal or nonfocal neurologic abnormality must be evaluated for serious illness. Abnormal findings on neurologic exam remain the single-best clinical predictor of intracranial pathology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/1,4,9\">",
"     1,4,9",
"    </a>",
"    ]. The findings may be quite subtle, such as slight pupillary asymmetry, unilateral pronator drift, or extensor plantar response, or pronounced, such as unilateral vision loss, ataxia, or seizure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38377?source=see_link\">",
"     \"The detailed neurologic examination in adults\"",
"    </a>",
"    .) Focal neurologic findings can accompany a number of secondary causes of headache, including intracranial hemorrhage, acute narrow angle glaucoma, and carotid or vertebral artery dissection. Nonfocal alterations in mental status more commonly characterize other secondary causes of headache, including SAH, infectious processes such as meningitis, toxins such as carbon monoxide, and metabolic derangements such as hypoxia.",
"   </p>",
"   <p>",
"    Neurologic abnormalities can also occur with migraine headaches. As an example, a visual field cut in both eyes within the same hemifield bounded by scintillations is characteristic of migraine with visual aura. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/4/26698?source=see_link&amp;anchor=H203275055#H203275055\">",
"     \"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults\", section on 'Migraine aura'",
"    </a>",
"    .) However, a focal neurologic deficit should not be assumed to be related to migraine unless similar deficits have occurred with migraine in the past. Any new or atypical focal neurologic deficit is considered a high-risk finding and should be investigated urgently in the emergency department. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Decreased level of consciousness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obtundation and confusion are not typical of a benign headache and increase the likelihood of meningitis, encephalitis, subarachnoid hemorrhage (SAH), or other space occupying lesion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=see_link\">",
"     \"Stupor and coma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Meningismus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningismus may indicate meningitis or SAH. It can be subtle. This sign is also less sensitive and less specific in adults older than 60 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\", section on 'Presenting manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Abnormal vital signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever can reflect CNS infection. It is not characteristic of migraine headache; it may, however, follow an SAH by a few days (",
"    <a class=\"graphic graphic_table graphicRef80966 \" href=\"mobipreview.htm?31/19/32059\">",
"     table 3",
"    </a>",
"    ). Although rare, severe hypertension (diastolic bp &ge;120 mmHg) can manifest as headache [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Toxic appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;A toxic appearing patient may be suffering from a CNS infection or a systemic illness affecting the CNS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Ophthalmologic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Papilledema, detected by blurring of the optic disks, is indicative of increased intracranial pressure, possibly due to a tumor or other structural abnormality. Retinal or subhyaloid hemorrhage can result from SAH. Decline or loss of vision can occur as a result of vascular compromise in temporal arteritis or carotid artery dissection, or as a result of increased intraocular pressure in acute narrow angle glaucoma (ANAG). Ciliary flush and sluggish pupillary light response can also occur with ANAG. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30552?source=see_link\">",
"     \"Overview and differential diagnosis of papilledema\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/54/9063?source=see_link\">",
"     \"Angle-closure glaucoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Traumatic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;External findings consistent with trauma raise concern for intracranial hemorrhage as the cause of headache. Such findings may include scalp or facial lacerations or contusions, hemotympanum, and periorbital or preauricular ecchymosis. Victims of abuse or other violence may not volunteer a history of trauma. Headache caused by a chronic subdural hemorrhage, although likely secondary to distant and perhaps mild trauma, will lack such immediate findings. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/25/3481?source=see_link\">",
"     \"Skull fractures in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/49/6936?source=see_link\">",
"     \"Subdural hematoma in adults: Etiology, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Additional findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of the temporal artery (eg, diminished pulse, swelling, or tenderness) are highly suggestive of temporal arteritis. Nausea and vomiting can accompany increased intracranial pressure, intracranial hemorrhage, or acute narrow angle glaucoma. A carotid bruit may accompany carotid artery dissection. Nasal discharge associated with sinus tenderness or signs of dental infection may reflect the cause of headache. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/50/34599?source=see_link\">",
"     \"Diagnosis of giant cell (temporal) arteritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/53/20313?source=see_link\">",
"     \"Complications, diagnosis, and treatment of odontogenic infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     LOW-RISK PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a history of prior headaches who present to the emergency department due to failure of their standard therapy regimen and who meet the following criteria can be considered at low-risk for dangerous headache:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No substantial change in their typical headache pattern",
"     </li>",
"     <li>",
"      No new concerning historical features (eg, seizure, trauma, fever)",
"     </li>",
"     <li>",
"      No focal neurologic symptoms or abnormal neurologic examination findings",
"     </li>",
"     <li>",
"      No high-risk comorbidity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Routine neuroimaging is not needed in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once historical and examination criteria have determined those patients with high-risk headache features, further evaluation is performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Neuroimaging and CSF evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of one or more high-risk features in a patient with an acute headache increases the possibility of a serious underlying illness and warrants more urgent evaluation with lumbar puncture, neuroimaging, or both (",
"    <a class=\"graphic graphic_algorithm graphicRef71604 graphicRef51917 \" href=\"mobipreview.htm?25/39/26230\">",
"     algorithm 1A-B",
"    </a>",
"    ). On the other hand, the yield of neuroimaging is very low if no high-risk historical feature is present and the neurologic examination is normal.",
"   </p>",
"   <p>",
"    As an example, a meta-analysis of published articles on the utilization of CT and MR scanning in patients presenting with headache conducted by the Quality Standards Subcommittee of the American Academy of Neurology revealed that abnormalities were present in only 2.4 percent of patients with a normal neurologic examination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/12\">",
"     12",
"    </a>",
"    ]. The incidence of pathology was even lower (0.4 percent) in patients whose headaches were typical of migraine and whose physical examination was normal.",
"   </p>",
"   <p>",
"    In patients who have a history or physical examination suggestive of serious pathology, the diagnostic approach depends upon the most likely suspected cause. A noncontrast head CT is most helpful for identifying intracranial lesions or bleeding; a lumbar puncture is most helpful for diagnosing infection.",
"   </p>",
"   <p>",
"    Lumbar puncture (LP) should",
"    <strong>",
"     always",
"    </strong>",
"    be performed in patients with suspected SAH in whom the CT scan is normal. One of the tragedies of contemporary emergency care is that those patients with SAH most amenable to treatment are the ones most frequently misdiagnosed at initial presentation. Such patients generally appear less ill and do not have neurologic deficits; misdiagnosis stems from a lack of appreciation of the range of possible presentations of patients with SAH [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/8\">",
"     8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link&amp;anchor=H26#H26\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients in whom suspicion for CNS infection is higher than for intracranial lesion, LP may be the first test of choice. Documented cases of herniation following LP have made some clinicians reluctant to perform the procedure without prior imaging in patients suspected of having intracranial pathology. In most such patients, however, LP alone is safe. In one prospective observational study that evaluated the need for cranial CT scan prior to LP, only 3 of 113 consecutive emergency department patients (2.7 percent) in whom an urgent lumbar puncture was thought to be necessary (not only for headache) had a CT abnormality that was a contraindication to LP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/13\">",
"     13",
"    </a>",
"    ]. Three clinical findings were associated with such an abnormality: papilledema, focal neurologic findings, and altered mental status. Another prospective study evaluating the need for preliminary cranial CT scan in patients with suspected meningitis found similar results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\", section on 'Lumbar puncture'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical policy statement on acute headache of the American College of Emergency Physicians gives a class C recommendation (ie, suggestion based upon weak evidence) to the performance of LP without prior neuroimaging in patients without evidence of increased intracranial pressure (ie, papilledema, absent venous pulsations on funduscopy, altered neurologic status, or focal neurologic deficits) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/11\">",
"     11",
"    </a>",
"    ]. An opening pressure should be measured when the LP is performed.",
"   </p>",
"   <p>",
"    Treatment with",
"    <strong>",
"    </strong>",
"    antibiotics",
"    <strong>",
"     must NOT be delayed",
"    </strong>",
"    in patients with suspected meningitis, regardless of the decision of whether to perform an imaging study. Detailed discussions of the interpretation of head CT and LP results are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/10/17576?source=see_link\">",
"     \"Cerebrospinal fluid: Physiology and utility of an examination in disease states\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9583453\">",
"    <span class=\"h2\">",
"     Traumatic lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A dilemma sometimes confronted in the ED is determining what additional work-up and disposition are appropriate for patients at risk for SAH whose head CT is unrevealing and whose initial LP is presumed to be traumatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/15\">",
"     15",
"    </a>",
"    ]. The clearing of blood in CSF collection tubes is",
"    <strong>",
"     NOT",
"    </strong>",
"    a reliable means of excluding SAH, unless a late or final collecting tube specimen is normal (ie, red blood cell count approaches zero). Xanthochromia, while useful, is not a foolproof means of diagnosing SAH. Interpretation of the LP is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link&amp;anchor=H28#H28\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Lumbar puncture'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One approach in such cases is to repeat the LP one intervertebral level cephalad to where the initial attempt was made (but no higher than",
"    <span class=\"nowrap\">",
"     L3/4)",
"    </span>",
"    or under fluoroscopic guidance. The presence of blood in CSF obtained from two LPs suggests SAH, possibly from a nonaneurysmal cause, while a normal specimen from the repeat LP makes SAH less likely. In cases where suspicion for SAH remains substantial, the head CT is unrevealing, and LP results are difficult to interpret, we recommend admission for further evaluation by neurology or neurosurgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=see_link&amp;anchor=H26#H26\">",
"     \"Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/50/38696?source=see_link\">",
"     \"Nonaneurysmal subarachnoid hemorrhage\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific laboratory tests can be helpful in evaluating possible causes of severe headache and are generally indicated by the patient's history and examination. Such tests can include complete blood count, electrolytes, glucose, BUN and creatinine, erythrocyte sedimentation rate and protein C (frequently elevated in temporal arteritis), coagulation studies, arterial blood gas, and carboxyhemoglobin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     DISPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients in whom a secondary cause of headache is discovered are admitted or referred to the appropriate setting. Patients in whom a secondary cause was suspected, but a thorough, appropriate workup was normal, should be treated symptomatically and may be discharged with primary care or neurologic follow-up. Of note, patient response to analgesics should not be used as a diagnostic tool and should",
"    <strong>",
"     NOT",
"    </strong>",
"    dissuade performance of LP when indicated by history or examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21054182\">",
"    <span class=\"h1\">",
"     TREATMENT OF UNDIFFERENTIATED HEADACHE IN THE EMERGENCY DEPARTMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relief of symptoms is an important part of management for patients presenting to the emergency department (ED) with severe headache, even when a thorough work-up reveals no clear underlying process. The large majority of these patients will ultimately be diagnosed with either a migraine or cluster headache. Details of migraine and cluster headache treatment are discussed separately (",
"    <a class=\"graphic graphic_table graphicRef68064 \" href=\"mobipreview.htm?40/58/41899\">",
"     table 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/44/21194?source=see_link\">",
"     \"Acute treatment of migraine in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3898?source=see_link\">",
"     \"Cluster headache: Acute and preventive treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For those patients with a primary headache disorder that does not clearly meet criteria for migraine or cluster headache, symptomatic treatment should be provided. Few studies are available to guide empiric management of undifferentiated headache in the ED; treatment remains symptom-based and largely nonspecific. Nevertheless, many of the treatments used for acute migraine headaches provide some relief in patients with a severe undifferentiated headache [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The authors of a systematic review of headache management in the ED propose the use of a parenterally administered nonsteroidal anti-inflammatory drug (NSAID) and a dopamine antagonist (DA) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/2\">",
"     2",
"    </a>",
"    ]. Their goal is to relieve pain, and allow the patient to return to baseline mental function without drowsiness. In the United States, this treatment would probably be",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/62/35808?source=see_link\">",
"     ketorolac",
"    </a>",
"    30 mg IV and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/28/22984?source=see_link\">",
"     prochlorperazine",
"    </a>",
"    10 mg.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"     Chlorpromazine",
"    </a>",
"    0.1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV might be used in place of prochlorperazine. Pretreatment with 12.5 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    or 1 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/55/3958?source=see_link\">",
"     benztropine",
"    </a>",
"    is suggested to avoid akathisia. In a small randomized trial, prochlorperazine was shown to be as effective as subcutaneous",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/38/5736?source=see_link\">",
"     sumatriptan",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For headaches unresponsive to treatment with a combination of NSAID and DA that have some migrainous features (eg, photophobia),",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/13/15574?source=see_link\">",
"     dihydroergotamine",
"    </a>",
"    1 mg IV may be effective. Other medications used to treat undifferentiated headache in the ED include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/38/5736?source=see_link\">",
"     sumatriptan",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/19/9527?source=see_link\">",
"     droperidol",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39704/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. The use of injectable opioids, while not encouraged, may be necessary for patients with contraindications to NSAIDs or medications with vasoconstrictive effects (eg, dihydroergotamine).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/31/3570?source=see_link\">",
"       \"Patient information: Headache (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/59/42931?source=see_link\">",
"       \"Patient information: Headache treatment in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/51/16179?source=see_link\">",
"       \"Patient information: Headache causes and diagnosis in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4727856\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A careful history and physical examination remain the most important part of the assessment of the headache patient.",
"     </li>",
"     <li>",
"      Historical and clinical features associated with dangerous causes of headache are summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef78567 \" href=\"mobipreview.htm?11/55/12155\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'High-risk historical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'High-risk examination findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abnormal findings on neurologic examination remain the single best clinical predictor of intracranial pathology. This includes alterations in mental status, visual changes, and changes in a migraine patient&rsquo;s typical pattern.",
"     </li>",
"     <li>",
"      The presence of one or more high-risk features in a patient with an acute headache increases the possibility of a serious underlying illness and warrants urgent evaluation with lumbar puncture, neuroimaging, or both. A flow chart to help guide the emergency department evaluation of the patient with headache is provided (",
"      <a class=\"graphic graphic_algorithm graphicRef71604 graphicRef51917 \" href=\"mobipreview.htm?25/39/26230\">",
"       algorithm 1A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Relief of symptoms is important, regardless of the headache&rsquo;s underlying cause. Treatment options are described in the text. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Disposition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21054182\">",
"       'Treatment of undifferentiated headache in the emergency department'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5576760\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/1\">",
"      Ramirez-Lassepas M, Espinosa CE, Cicero JJ, et al. Predictors of intracranial pathologic findings in patients who seek emergency care because of headache. Arch Neurol 1997; 54:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/2\">",
"      Torelli P, Campana V, Cervellin G, Manzoni GC. Management of primary headaches in adult Emergency Departments: a literature review, the Parma ED experience and a therapy flow chart proposal. Neurol Sci 2010; 31:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/3\">",
"      Edmeads J. Emergency management of headache. Headache 1988; 28:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/4\">",
"      Locker TE, Thompson C, Rylance J, Mason SM. The utility of clinical features in patients presenting with nontraumatic headache: an investigation of adult patients attending an emergency department. Headache 2006; 46:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/5\">",
"      Ward TN, Levin M, Phillips JM. Evaluation and management of headache in the emergency department. Med Clin North Am 2001; 85:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/6\">",
"      Rothman RE, Keyl PM, McArthur JC, et al. A decision guideline for emergency department utilization of noncontrast head computed tomography in HIV-infected patients. Acad Emerg Med 1999; 6:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/7\">",
"      Pascual J, Berciano J. Experience in the diagnosis of headaches that start in elderly people. J Neurol Neurosurg Psychiatry 1994; 57:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/8\">",
"      Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med 2000; 342:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/9\">",
"      Detsky ME, McDonald DR, Baerlocher MO, et al. Does this patient with headache have a migraine or need neuroimaging? JAMA 2006; 296:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/10\">",
"      Miller LG, Choi C. Meningitis in older patients: how to diagnose and treat a deadly infection. Geriatrics 1997; 52:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/11\">",
"      American College of Emergency Physicians.. Clinical policy: critical issues in the evaluation and management of patients presenting to the emergency department with acute headache. Ann Emerg Med 2002; 39:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/12\">",
"      Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1994; 44:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/13\">",
"      Gopal AK, Whitehouse JD, Simel DL, Corey GR. Cranial computed tomography before lumbar puncture: a prospective clinical evaluation. Arch Intern Med 1999; 159:2681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/14\">",
"      Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/15\">",
"      Shah KH, Richard KM, Nicholas S, Edlow JA. Incidence of traumatic lumbar puncture. Acad Emerg Med 2003; 10:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/16\">",
"      Miner JR, Smith SW, Moore J, Biros M. Sumatriptan for the treatment of undifferentiated primary headaches in the ED. Am J Emerg Med 2007; 25:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/17\">",
"      Swadron SP. Pitfalls in the management of headache in the emergency department. Emerg Med Clin North Am 2010; 28:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/18\">",
"      Kostic MA, Gutierrez FJ, Rieg TS, et al. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med 2010; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/19\">",
"      Trainor A, Miner J. Pain treatment and relief among patients with primary headache subtypes in the ED. Am J Emerg Med 2008; 26:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/20\">",
"      Hill CH, Miner JR, Martel ML. Olanzapine versus droperidol for the treatment of primary headache in the emergency department. Acad Emerg Med 2008; 15:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39704/abstract/21\">",
"      Friedman BW, Lipton RB. Headache emergencies: diagnosis and management. Neurol Clin 2012; 30:43.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 287 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-C80C007BE0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39704=[""].join("\n");
var outline_f38_49_39704=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4727856\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HIGH-RISK HISTORICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Sudden onset",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      No similar headaches in the past",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Concomitant infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Altered mental status or seizure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Headache with exertion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Age over 50",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      HIV and immunosuppression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Visual disturbances",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Location of pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Family history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6723177\">",
"      Illicit drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4699896\">",
"      Toxic exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Additional history",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      HIGH-RISK EXAMINATION FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Neurologic abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Decreased level of consciousness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Meningismus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Abnormal vital signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Toxic appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Ophthalmologic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Traumatic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Additional findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      LOW-RISK PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Neuroimaging and CSF evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9583453\">",
"      Traumatic lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      DISPOSITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21054182\">",
"      TREATMENT OF UNDIFFERENTIATED HEADACHE IN THE EMERGENCY DEPARTMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4727856\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5576760\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/287\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/287|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?17/44/18112\" title=\"algorithm 1A\">",
"      Headache in ER I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?10/42/10914\" title=\"algorithm 1B\">",
"      Headache in ER II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/287|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?11/55/12155\" title=\"table 1\">",
"      Characteristic serious headache",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/16/27915\" title=\"table 2\">",
"      Diff dx sudden severe headache",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?31/19/32059\" title=\"table 3\">",
"      Diff dx headache with fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?40/58/41899\" title=\"table 4\">",
"      Common headache syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/48/39688?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/44/21194?source=related_link\">",
"      Acute treatment of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/54/9063?source=related_link\">",
"      Angle-closure glaucoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/10/41128?source=related_link\">",
"      Approach to HIV-infected patients with central nervous system lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/6/10345?source=related_link\">",
"      Carbon monoxide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/10/17576?source=related_link\">",
"      Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/25/35225?source=related_link\">",
"      Clinical manifestations of Lyme disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/33/18969?source=related_link\">",
"      Clinical manifestations of giant cell (temporal) arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3898?source=related_link\">",
"      Cluster headache: Acute and preventive treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14327?source=related_link\">",
"      Cluster headache: Epidemiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/53/20313?source=related_link\">",
"      Complications, diagnosis, and treatment of odontogenic infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/50/34599?source=related_link\">",
"      Diagnosis of giant cell (temporal) arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7594?source=related_link\">",
"      Etiology, clinical features, and diagnosis of cerebral venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/39/38522?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/39/39545?source=related_link\">",
"      Evaluation and management of the cardiovascular complications of cocaine abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32953?source=related_link\">",
"      Headache, migraine, and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=related_link\">",
"      Management of acute severe traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/50/38696?source=related_link\">",
"      Nonaneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30552?source=related_link\">",
"      Overview and differential diagnosis of papilledema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/13/38104?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/20/330?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of spontaneous low cerebrospinal fluid pressure headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/4/26698?source=related_link\">",
"      Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/31/3570?source=related_link\">",
"      Patient information: Headache (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/51/16179?source=related_link\">",
"      Patient information: Headache causes and diagnosis in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/59/42931?source=related_link\">",
"      Patient information: Headache treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=related_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42889?source=related_link\">",
"      Preventive treatment of migraine in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/37/22101?source=related_link\">",
"      Primary cough headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/20/44356?source=related_link\">",
"      Primary exertional headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/25/3481?source=related_link\">",
"      Skull fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=related_link\">",
"      Stupor and coma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/49/6936?source=related_link\">",
"      Subdural hematoma in adults: Etiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38377?source=related_link\">",
"      The detailed neurologic examination in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_49_39705="Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy";
var content_f38_49_39705=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39705/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39705/contributors\">",
"     Silvano Loperfido, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39705/contributors\">",
"     Guido Costamagna, MD, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39705/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39705/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/49/39705/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/49/39705/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/49/39705/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic retrograde cholangiopancreatography (ERCP) is an endoscopic technique in which a specialized side-viewing upper endoscope is guided into the duodenum, allowing for instruments to be passed into the bile and pancreatic ducts. These are opacified by injection of a contrast medium, thereby permitting their visualization and allowing for a variety of therapeutic interventions. It is a relatively complex endoscopic procedure since it requires specialized equipment and has a long learning curve to develop proficiency. Its benefits in the minimally invasive management of biliary and pancreatic disorders are challenged by a higher potential for serious complications than any other standard endoscopic technique.",
"   </p>",
"   <p>",
"    Similar to other endoscopic procedures, determinants of ERCP procedural safety include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Indication (appropriate or questionable)",
"     </li>",
"     <li>",
"      Sedation and monitoring practice",
"     </li>",
"     <li>",
"      Patient age and clinical condition",
"     </li>",
"     <li>",
"      Specific procedures performed (diagnostic or therapeutic)",
"     </li>",
"     <li>",
"      Setting and equipment of the endoscopy unit",
"     </li>",
"     <li>",
"      Training and competence of endoscopist and endoscopic team",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At least 180 procedures are required for a trainee to acquire a level of competence in diagnostic and therapeutic ERCP, defined by deep cannulation of the bile duct in 70 to 80 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/2\">",
"     2",
"    </a>",
"    ]. This is still below the optimal standard of 90 to 95 percent success when the procedure is performed by experts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/3\">",
"     3",
"    </a>",
"    ]. An adequate volume of activity is also needed to maintain proficiency. Individual endoscopists who perform more than 40 endoscopic sphincterotomies per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/4\">",
"     4",
"    </a>",
"    ] or at least one per week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5\">",
"     5",
"    </a>",
"    ] have a lower complication rate than those who perform fewer procedures.",
"   </p>",
"   <p>",
"    This topic will review the indications for ERCP and will provide an overview of the complications associated with diagnostic and therapeutic ERCP, including their definition, classification, incidence, and risk factors. Specific complications of ERCP and biliary sphincterotomy are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23959?source=see_link\">",
"     \"Post-ERCP septic complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/38/26216?source=see_link\">",
"     \"Post-ERCP bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/38/20072?source=see_link\">",
"     \"Post-ERCP perforation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7882?source=see_link\">",
"     \"Rare complications of ERCP\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for ERCP have been proposed in consensus statements [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/6\">",
"     6",
"    </a>",
"    ] and guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/7\">",
"     7",
"    </a>",
"    ]. The need for recognizing accepted indications for ERCP is underscored by the observation that malpractice litigation surrounding ERCP frequently involves disputes regarding the appropriateness of the indications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/8\">",
"     8",
"    </a>",
"    ]. There is general consensus that ERCP should be done for good indications, by trained endoscopists using standard techniques, with well documented patient informed consent, and communication before and after the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Complications should be recognized and managed early, and there should be honest and compassionate communication with the family and patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     National Institutes of Health",
"    </span>",
"    &nbsp;&mdash;&nbsp;A consensus development conference sponsored by the National Institutes of Health in 2002 developed a statement regarding the indications for ERCP. The following summarizes the conclusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/6\">",
"     6",
"    </a>",
"    ] (",
"    <a class=\"external\" href=\"file://consensus.nih.gov/2002/2002ERCPsos020html.htm\">",
"     file://consensus.nih.gov/2002/2002ERCPsos020html.htm",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ERCP, magnetic resonance cholangiopancreatography, and endoscopic ultrasonography have comparable sensitivity and specificity in the diagnosis of choledocholithiasis.",
"     </li>",
"     <li>",
"      Patients undergoing cholecystectomy do not require an ERCP preoperatively if there is a low probability of having choledocholithiasis.",
"     </li>",
"     <li>",
"      Laparoscopic common bile duct exploration and postoperative ERCP are both safe and reliable in clearing common bile duct stones.",
"     </li>",
"     <li>",
"      ERCP with sphincterotomy and stone removal is a valuable therapeutic modality in choledocholithiasis with jaundice, dilated common bile duct, acute pancreatitis, or cholangitis.",
"     </li>",
"     <li>",
"      In patients with pancreatic or biliary cancer, the principal advantage of ERCP is palliation of biliary obstruction when surgery is not elected.",
"     </li>",
"     <li>",
"      Tissue sampling for patients with pancreatic or biliary cancer not undergoing surgery may be achieved by ERCP, but this is not always diagnostic.",
"     </li>",
"     <li>",
"      ERCP is the best means to diagnose ampullary cancers.",
"     </li>",
"     <li>",
"      ERCP has no role in the diagnosis of acute pancreatitis except when biliary pancreatitis is suspected. In patients with severe biliary pancreatitis, early intervention with ERCP reduces morbidity and mortality compared with delayed ERCP.",
"     </li>",
"     <li>",
"      ERCP with appropriate therapy is beneficial in selected patients who have either recurrent pancreatitis or pancreatic pseudocysts.",
"     </li>",
"     <li>",
"      Patients with type I sphincter of Oddi dysfunction (SOD) respond to sphincterotomy.",
"     </li>",
"     <li>",
"      Patients with type II SOD should not undergo diagnostic ERCP alone. If sphincter of Oddi manometric pressures are &gt;40 mmHg, endoscopic sphincterotomy is beneficial in some patients.",
"     </li>",
"     <li>",
"      Avoidance of unnecessary ERCP is the best way to reduce the number of complications.",
"     </li>",
"     <li>",
"      ERCP should be avoided if there is a low likelihood of biliary stone or stricture, especially in women with recurrent pain, a normal bilirubin, and no other objective sign of biliary disease.",
"     </li>",
"     <li>",
"      Endoscopists performing ERCP should have appropriate training and expertise before performing advanced procedures.",
"     </li>",
"     <li>",
"      With newer diagnostic imaging technologies emerging, ERCP is evolving into a predominantly therapeutic procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     American Society of Gastrointestinal Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several points related to ERCP were summarized in a guideline published by the American Society of Gastrointestinal Endoscopy in 2005 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/7\">",
"     7",
"    </a>",
"    ]. The recommendations were graded based upon the supporting data (\"A\" for prospective controlled trials; \"B\" for observational studies; \"C\" for expert opinion).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ERCP is primarily a therapeutic procedure for the management of pancreaticobiliary disorders (C).",
"     </li>",
"     <li>",
"      Diagnostic ERCP should not be undertaken in the evaluation of pancreaticobiliary pain in the absence of objective findings on other imaging studies (B).",
"     </li>",
"     <li>",
"      Routine ERCP before laparoscopic cholecystectomy should not be performed (B).",
"     </li>",
"     <li>",
"      Endoscopic therapy of postoperative biliary leaks and strictures should be undertaken as first-line therapy (B).",
"     </li>",
"     <li>",
"      ERCP has an important role in patients with recurrent acute pancreatitis and can identify and, in some cases, treat the underlying cause (B).",
"     </li>",
"     <li>",
"      ERCP is effective in treating symptomatic strictures in chronic pancreatitis (B).",
"     </li>",
"     <li>",
"      ERCP is effective for the palliation of malignant biliary obstruction (B), for which self-expanding metallic stents have longer patency than plastic stents (A).",
"     </li>",
"     <li>",
"      ERCP can be used to diagnose and to treat symptomatic pancreatic-duct stones (B).",
"     </li>",
"     <li>",
"      Pancreatic-duct disruptions or leaks can be effectively treated via the placement of bridging or transpapillary pancreatic stents (B).",
"     </li>",
"     <li>",
"      ERCP is a highly effective tool to drain symptomatic pancreatic pseudocysts and, in selected patients, more complicated benign pancreatic-fluid collections arising in patients with a history of pancreatitis (B).",
"     </li>",
"     <li>",
"      Intraductal ultrasound and pancreatoscopy are useful adjunctive techniques for the diagnosis of pancreatic malignancies (B).",
"     </li>",
"     <li>",
"      ERCP can be performed safely in both children and pregnant women by experienced endoscopists. In both situations, radiation exposure should be minimized as much as possible (B).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84322493\">",
"    <span class=\"h1\">",
"     INFORMED CONSENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications are expected to occur in a predictable proportion of patients undergoing ERCP, even in expert hands. A number of patient-related and technique-related factors are known to increase the risk of complications. It is not uncommon for malpractice claims or lawsuits related to complications to be decided in favor of the plaintiff [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/8,11\">",
"     8,11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Risk factors for overall complications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients should be made aware of the risks associated with the procedure during procurement of informed consent. The informed consent process varies according to the ethics of the medical profession and the rules of each country, but it typically requires that the patient has adequate awareness of who the operator will be, the specific benefits and risks of the procedure, and possible alternatives.",
"   </p>",
"   <p>",
"    One should also note that malpractice claims or lawsuits related to complications are serious troubles for the operator, administration, and insurance company [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/8,11\">",
"     8,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84322500\">",
"    <span class=\"h1\">",
"     MONITORING DURING AND AFTER ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful clinical monitoring of the patient by the operator and assistants is mandatory since ERCP is a complex procedure that is often performed for therapeutic purposes and requires conscious sedation. Electronic monitoring devices such as pulse oximetry enhance the safety of conscious sedation and are commonly used. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=see_link\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient is ordinarily kept fasting before the procedure. Following the procedure, most experienced endoscopists will have patients who are at high- or moderate-risk of complications continue to fast, or they will advance the diet to clear liquids only [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/12\">",
"     12",
"    </a>",
"    ]. Such patients may resume their normal diet the next morning. Patients who are at low-risk of complications can have their diet advanced gradually over four to six hours. A routine measurement of serum pancreatic enzymes prior to the procedure and later for early detection of post-ERCP pancreatitis has been recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many complications of ERCP are apparent during the first six hours after the procedure. Thus, patients should be carefully monitored during the recovery phase after ERCP to detect symptoms or signs suggestive of adverse events. This is particularly important in patients with factors predictive of complications, especially since ERCP is increasingly being performed on an outpatient basis, even after relatively riskier procedures such as endoscopic sphincterotomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H84322341\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Definition and classification of complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum of negative outcomes of endoscopic procedures includes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/15-19\">",
"     15-19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complications: undesired events that require management by a clinician and unplanned admission or prolongation of planned hospital stay",
"     </li>",
"     <li>",
"      Incidents: undesired events that do not qualify as complications",
"     </li>",
"     <li>",
"      Adverse sequelae: adverse but inevitable results of the procedure, such as the loss of sphincter activity due to sphincterotomy",
"     </li>",
"     <li>",
"      Technical failures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ERCP-related complications can be divided into two main groups:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      General complications, common to all endoscopic procedures, like medication reactions, oxygen desaturation, cardiopulmonary accidents, and hemorrhage or perforation induced by traumatic passage of the endoscope",
"     </li>",
"     <li>",
"      Selective complications, specific to pancreatobiliary instrumentation, including pancreatitis, sepsis, and hemorrhage or retroperitoneal duodenal perforation following therapeutic procedures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A 1991 consensus panel introduced a standardized, outcome-based set of definitions and grading system for the major complications of ERCP and endoscopic sphincterotomy (",
"    <a class=\"graphic graphic_table graphicRef73512 graphicRef71241 \" href=\"mobipreview.htm?21/44/22221\">",
"     table 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complications may be focal, occurring at the point of endoscopic contact (eg, perforation, bleeding, pancreatitis), or nonspecific, occurring in organs not traversed or touched (eg, cardiopulmonary problems) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      With regard to timing, complications may be early or late, with a conventional cut-off at 30 days. The first group includes immediate, early, and delayed events, while the latter includes focal direct complications occurring after 30 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The severity of complications can be expressed in terms of the length of hospital stay, the need for transfusions, intensive care unit assistance, surgical, radiologic or endoscopic interventions, and any resulting permanent disability, and death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/15-18\">",
"       15-18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Reporting complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incidence rates of post-ERCP complications vary widely, depending largely upon the definition adopted, the methods of data collection, and the case mix (selection of the patients and techniques used) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/20\">",
"     20",
"    </a>",
"    ]. Retrospective surveys inevitably underestimate the frequency of adverse events. However, even prospective surveys are prone to measurement biases if the modality of data collection does not use strict criteria.",
"   </p>",
"   <p>",
"    Prospective surveys from single referral centers ensure the highest accuracy but are unlikely to be representative of the frequency and severity of unfavorable events in practice. By comparison, prospective multicenter studies involving centers with different volumes of activity and operators with various degrees of expertise more reliably reflect the general effectiveness and safety of the endoscopic procedures on the pancreaticobiliary ducts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5,21\">",
"     5,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Incidence rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have evaluated the incidence of post-ERCP complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5,22-24\">",
"     5,22-24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific complications (pancreatitis, bleeding, sepsis, and perforation) &ndash; In a summary of 21 studies involving 16,855 patients between 1987 and 2003, specific complications totaled 1154 (6.9 percent), with 55 deaths (0.33 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/22\">",
"       22",
"      </a>",
"      ]. Mild-to-moderate events occurred in 872 patients (5.2 percent), and severe events in 282 (1.7 percent). Similar rates of specific complications (5.3 percent) and deaths (0.34 percent) were reported in two subsequent prospective studies involving a total of 7252 patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/23,24\">",
"       23,24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nonspecific complications &ndash; Among 12,973 patients enrolled in 14 prospective studies, general complications totaled 173 (1.3 percent), with nine deaths (0.07 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/22\">",
"       22",
"      </a>",
"      ]. A similar rate of nonspecific complications (0.87 percent) was noted in two subsequent prospective studies involving a total of 7252 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/23,24\">",
"       23,24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite technological progress and recommendations of scientific societies, the incidence of complications and procedure-related mortality do not appear to have changed significantly with time. In an Austrian study that included 13,514 ERCPs performed between 2006 and 2009, the overall complication and mortality rates were 10 and 0.1 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/25\">",
"     25",
"    </a>",
"    ]. Similarly, in a Norwegian study with 2808 ERCPs performed between 2007 and 2009, the overall complication and mortality rates were 12 and 1.4 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/26\">",
"     26",
"    </a>",
"    ]. One possible reason why complication rates have not declined is that with time, ERCP has become a primarily therapeutic procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Specific complications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most frequent complication of ERCP is pancreatitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bleeding during ERCP typically develops after sphincterotomy. As for all endoscopic procedures, patients should be screened for a history of excessive bleeding and the use of anticoagulants or antiplatelet agents. A platelet count and prothrombin time should be routinely checked in patients undergoing ERCP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/38/26216?source=see_link\">",
"     \"Post-ERCP bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections occurring after ERCP are most often due to manipulation of an obstructed biliary or pancreatic system. Less commonly, infection can be introduced by contaminated endoscopic equipment, which is extremely unlikely if proper disinfection methods have been used. The American Heart Association (AHA) and the American Society of Gastrointestinal Endoscopy have issued guidelines for antibiotic prophylaxis prior to endoscopic procedures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/25/41367?source=see_link\">",
"     \"Antibiotic prophylaxis for gastrointestinal endoscopic procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is imperative to achieve effective drainage in patients with biliary obstruction. Thus, diagnostic ERCP should not be performed in such patients without the capability of providing immediate endoscopic drainage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23959?source=see_link\">",
"     \"Post-ERCP septic complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;ERCP may rarely be complicated by perforation of the esophagus, stomach, duodenum, or jejunum. The risk is increased in patients with stenosis of any of these segments and in patients who have undergone gastric resection. Retroperitoneal duodenal perforation can occur, usually secondary to sphincterotomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/38/20072?source=see_link\">",
"     \"Post-ERCP perforation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Nonspecific complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;ERCP is associated with a number of complications common to other procedures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7882?source=see_link\">",
"     \"Rare complications of ERCP\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Medication-related complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients undergoing ERCP require sedation or anesthesia. The usual preparation is conscious sedation with intravenous benzodiazepines and frequent addition of analgesic opiates; general anesthesia is used only in specific circumstances (such as in children or patients at increased risk for respiratory complications) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/28\">",
"     28",
"    </a>",
"    ]. A variety of complications from conscious sedation have been described. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28310?source=see_link\">",
"     \"Complications of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Experience with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    (a short-acting hypnotic agent) for endoscopic procedures is accumulating. However, it is a respiratory depressant with a narrow therapeutic window [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/28\">",
"     28",
"    </a>",
"    ]. As a result, it needs to be administered by specially trained personnel who are not directly involved in the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Recommendations for the appropriate personnel and equipment needed for propofol sedation have been issued in a 2002 consensus statement from the American Society for Gastrointestinal Endoscopy (",
"    <a class=\"graphic graphic_table graphicRef62941 \" href=\"mobipreview.htm?12/60/13259\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/31\">",
"     31",
"    </a>",
"    ], in a 2009",
"    <a class=\"external\" href=\"file://www.asge.org/uploadedFiles/Publications_and_Products/Practice_Guidelines/NAAP Propofol Position Statement Dec GIE FINAL.pdf\">",
"     joint position statement",
"    </a>",
"    endorsed by the American Association for the Study of the Liver, the American College of Gastroenterology, the American Gastroenterological Association, and the American Society of Gastrointestinal Endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/32\">",
"     32",
"    </a>",
"    ], and in a 2010",
"    <a class=\"external\" href=\"file://www.esge.com/assets/downloads/pdfs/guidelines/2010_non_anesthesiologist_admin_propofol_gi_endo.pdf\">",
"     guideline",
"    </a>",
"    from the European Society of Gastrointestinal Endoscopy that specifically focused on the use of propofol by non-anesthesiologists in healthy, low-risk patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/2/43049?source=see_link\">",
"     \"Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h4\">",
"     Anticholinergic side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticholinergic agents are commonly used to inhibit motor and secretory activity of the intestinal tract. These drugs can have effects on cardiac function that require monitoring. In addition, they can increase intraocular pressure in patients with narrow-angle glaucoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/1\">",
"     1",
"    </a>",
"    ]. Glucagon is an alternative to anticholinergic agents as an aid in endoscopic or radiologic examinations to temporarily inhibit the intestinal tract movement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h4\">",
"     Contrast allergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anaphylactic reactions to contrast agents used during ERCP are rare [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/34\">",
"     34",
"    </a>",
"    ]. There were no reactions reported in a prospective study of ERCP using standard high osmolarity contrast media without the use of prophylactic medications in 601 patients, 80 of whom had a history of prior contrast allergic reactions. The authors concluded that premedication, regardless of history, was unnecessary when performing ERCP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/35\">",
"     35",
"    </a>",
"    ]. Nevertheless, a history of sensitivity to iodine contrast or drug should always be considered in the preprocedure assessment and in the informed consent process. In patients with prior allergy to contrast media, prophylactic measures adopted by most endoscopists include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/36\">",
"     36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Use of",
"      <span class=\"nowrap\">",
"       nonionic/low",
"      </span>",
"      osmolarity contrast media. Gadolinium has been suggested as an alternative contrast agent for ERCP in the iodine-allergic patient [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Premedication with oral steroids starting the day before ERCP, or intravenous steroids when an allergy is discovered just before the procedure. Some endoscopists also give an intravenous antihistamine in combination with the steroids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h4\">",
"     Oversedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The deeper sedation used during ERCP increases the risk of oxygen desaturation compared with other endoscopic procedures. Patients with preexisting respiratory diseases, the elderly, and those with comorbidities are at particular risk since they may be more sensitive to sedatives and the effects of desaturation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/38\">",
"     38",
"    </a>",
"    ]. Thus,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/6/41062?source=see_link\">",
"     flumazenil",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/24/35207?source=see_link\">",
"     naloxone",
"    </a>",
"    should always be available. Other side effects of benzodiazepines include paradoxical reactions and phlebitis, the latter occurring more commonly with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    than with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Cardiopulmonary complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiopulmonary complications such as aspiration, hypoxemia, and cardiac dysrhythmia are observed most commonly in patients with underlying chronic heart or lung disease and are more common in the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/39\">",
"     39",
"    </a>",
"    ]. However, severe respiratory and cardiac side effects are infrequent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5,21\">",
"     5,21",
"    </a>",
"    ]. Gas embolisms should be considered (among other possibilities) in patients who develop sudden, severe cardiopulmonary events during ERCP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7882?source=see_link\">",
"     \"Rare complications of ERCP\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H543587980\">",
"    <span class=\"h4\">",
"     Carbon dioxide insufflation versus air insufflation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gas insufflation during endoscopy stretches the abdomen, may lead to post-ERCP pain and discomfort, and can contribute to cardiopulmonary complications. While ambient air is not absorbed by the bowel, CO",
"    <sub>",
"     2",
"    </sub>",
"    is rapidly absorbed from the bowel and is delivered to the lungs by the circulation. Therefore CO",
"    <sub>",
"     2",
"    </sub>",
"    has the potential to reduce post-ERCP pain and discomfort, but this potential advantage may be offset by hypercapnia and cardiopulmonary side effects in elderly patients. The use of CO",
"    <sub>",
"     2",
"    </sub>",
"    insufflation during ERCP is controversial, but according to a meta-analysis involving 818 patients in seven randomized controlled trials, CO",
"    <sub>",
"     2",
"    </sub>",
"    insufflation during ERCP appeared safe and reduced abdominal pain and discomfort compared with air insufflation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Electrosurgical hazards",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two potential complications are associated with electrocautery. Excessive cautery can lead to thermal injury and perforation, while inadequate cautery increases the risk of bleeding. In addition, electrocautery can influence implantable devices such as pacemakers and defibrillators. Although most modern pacemakers are unaffected by electrocautery, cardiac arrhythmias may develop if monopolar current passes through the pacemaker or the heart [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/41\">",
"     41",
"    </a>",
"    ]. The risk is greater for implantable cardioverter-defibrillators since electrocautery may trigger their activation. As a result, the American Society for Gastrointestinal Endoscopy Technology Assessment Committee recommends that implantable cardioverter-defibrillators be deactivated during endoscopic electrosurgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Miscellaneous complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of rare complications have been reported. These include gallstone ileus, colonic perforation, liver abscess, splenic, hepatic or vascular trauma, pneumothorax, gas embolism, impaction of retrieval baskets, complications related to biliary and pancreatic stents, biloma, and others. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7882?source=see_link\">",
"     \"Rare complications of ERCP\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Diagnostic versus therapeutic ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of reports have suggested that the risk of complications is increased when ERCP includes a therapeutic intervention compared with pancreaticobiliary imaging alone. The frequency of complications may be expected to increase since ERCP is increasingly becoming a therapeutic procedure. As an example, two-thirds of the procedures were therapeutic in a prospective survey of 2769 patients in North-East Italy from 1992 to 1994 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/21\">",
"     21",
"    </a>",
"    ]. This proportion is expected to increase due to the availability of new effective diagnostic tools such as MR cholangiopancreatography and endoscopic ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/41,43\">",
"     41,43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23351?source=see_link\">",
"     \"Magnetic resonance cholangiopancreatography\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/43/8884?source=see_link\">",
"     \"Endoscopic ultrasound: Normal pancreaticobiliary anatomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/34/43557?source=see_link\">",
"     \"Endoscopic ultrasound in patients with suspected choledocholithiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/57/29591?source=see_link\">",
"     \"Endoscopic ultrasound in chronic pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most studies of ERCP complications have focused on sphincterotomy. Sphincterotomy is the most commonly performed procedure during ERCP that is associated with an increased risk of complications. Less has been published about the risk of diagnostic ERCP without sphincterotomy.",
"   </p>",
"   <p>",
"    At least three studies from Europe found that serious adverse complications were more likely when a therapeutic procedure, was performed compared with imaging alone (5 to 10 percent versus 1 to 3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/21,44,45\">",
"     21,44,45",
"    </a>",
"    ]. The performance of a biliary sphincterotomy was an independent risk factor for complications in a retrospective review involving 11,487 procedures over 12 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Risk factors for overall complications'",
"    </a>",
"    below.) One report also found an increase in mortality with a therapeutic procedure (0.5 versus 0.2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the relative safety of diagnostic ERCP compared with therapeutic ERCP, complications associated with diagnostic ERCP are by no means negligible. Serious complications including pancreatitis, cholangitis, free abdominal duodenal perforation, and other nonspecific adverse events can occur. This was underscored in a Danish study reporting on 39 consecutive claims for compensation due to complications after ERCP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/11\">",
"     11",
"    </a>",
"    ]. Among nine fatal cases, the procedure was diagnostic in six, although two out of the six patients had abnormal findings on cholangiogram.",
"   </p>",
"   <p>",
"    Specific interventions are associated with different degrees of risk and types of adverse outcomes. As examples, in one report, biliary sphincterotomy increased the acute procedural morbidity of endoscopic placement of biliary endoprostheses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/47\">",
"     47",
"    </a>",
"    ], while in another series endoscopic sphincterotomy was among the independent risk factors for admission after outpatient therapeutic ERCP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/14\">",
"     14",
"    </a>",
"    ]. In some studies, precut sphincterotomy, a controversial invasive technique used to achieve selective bile duct cannulation in difficult cases, was an independent risk factor for overall complications of ERCP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5,21,45,48\">",
"     5,21,45,48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/10/25767?source=see_link\">",
"     \"Precut (access) papillotomy\"",
"    </a>",
"    .) Complex procedures were an independent predictor of severe or fatal complications in a large study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/46\">",
"     46",
"    </a>",
"    ]. Although considered to be a diagnostic procedure, sphincter of Oddi manometry is associated with an increased risk of pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations suggest that, in some settings, purely diagnostic ERCP may not be less dangerous than therapeutic ERCP. Furthermore, diagnostic ERCP may be more dangerous than therapeutic ERCP if a required therapeutic procedure (such as achieving adequate biliary drainage) is not achieved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Sphincterotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most data on sphincterotomy early complications were derived from retrospective series that are more than a decade old; commonly quoted rates of complications were about 10 percent, with an overall mortality of about 1.5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar complication rates were observed in at least two prospective studies (",
"    <a class=\"graphic graphic_table graphicRef66631 \" href=\"mobipreview.htm?8/0/8205\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5,50\">",
"     5,50",
"    </a>",
"    ]. However, closer inspection of these data reveals that the types of complications have changed during the past two decades. In a review of 3498 patients who underwent ERCP during a 25-year period from 1973 to 1997, the rate of hemorrhage and perforation decreased from 3 to 2 percent and from 1 to 0.2 to 0.3 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/50\">",
"     50",
"    </a>",
"    ]. At the same time, the rate of pancreatitis increased from 2 to about 5 percent due to more accurate diagnosis and standardized modalities of data collection. These observations can be interpreted as suggesting that the overall complication rate of sphincterotomy has probably decreased during the last decade. This interpretation is supported by a reduction in the procedure-related mortality rate from more than 1 to about 0.5 percent (",
"    <a class=\"graphic graphic_table graphicRef66631 \" href=\"mobipreview.htm?8/0/8205\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Late complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term complications following endoscopic sphincterotomy include stone recurrence, papillary stenosis, and cholangitis, which occur in approximately 6 to 24 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/23/22905?source=see_link\">",
"     \"Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Papillary stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenosis of the ampulla of Vater can occur as a long-term complication of ERCP with sphincterotomy. It has been described in 1 to 4 percent of patients who underwent sphincterotomy for bile duct stones, depending in part upon how stenosis was defined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. Endoscopic treatment (with stenting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    balloon dilation) can be effective. Complications of such therapy occurred in 8 of 49 patients (16 percent) in one series, and included severe bleeding, perforation, and pancreatitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Risk factors for overall complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several multicenter studies involving large numbers of patients in community and tertiary environments have identified risk factors associated with complications (",
"    <a class=\"graphic graphic_table graphicRef61715 \" href=\"mobipreview.htm?13/42/13997\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5,21,23,24,45,46,55,56\">",
"     5,21,23,24,45,46,55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Independent risk factors for overall complications recognized in most studies include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Operator-related factors (low ERCP case volume)",
"     </li>",
"     <li>",
"      Method-related factors (difficulty of cannulation, biliary sphincterotomy, and precut sphincterotomy)",
"     </li>",
"     <li>",
"      Patient-related factors (sphincter of Oddi dysfunction, periampullary diverticulum, and cirrhosis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several additional risk factors have been suggested in other reports including older age, comorbid diseases, small bile duct diameter, emergency procedures, and Billroth II gastrectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/57\">",
"     57",
"    </a>",
"    ]. While these conditions have not been proven to increase the risk of overall complications of ERCP in multivariate analyses, some can increase the risk of selective complications, such as intestinal perforation in patients with a Billroth II and cardiopulmonary complications in elderly patients with comorbidities. Severe systemic disease was an independent predictor of severe or fatal complications in a large retrospective study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/46\">",
"     46",
"    </a>",
"    ]. On the other hand, some factors may be protective; the incidence of post-procedural pancreatitis, for example, is reduced in the elderly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5,21,58\">",
"     5,21,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hospital volume also appears to correlate with outcomes. A database study involving 2629 hospitals (and 199,625 ERCPs performed on inpatients) found a significantly lower procedural failure rate and shorter length of stay in hospitals performing &ge;200 ERCPs per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     ASSURING GOOD QUALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Society for Gastrointestinal Endoscopy has identified a number of quality indicators that can be monitored to help assure that ERCP is performed safely [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/60\">",
"     60",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age, patient comorbidity and American Society of Anesthesia (ASA) classification of risk",
"     </li>",
"     <li>",
"      Endoscopists' procedure volume",
"     </li>",
"     <li>",
"      Procedure indication and intent",
"     </li>",
"     <li>",
"      Procedure difficulty [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/61\">",
"       61",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Unplanned events",
"     </li>",
"     <li>",
"      Patient satisfaction",
"     </li>",
"     <li>",
"      Technical success",
"     </li>",
"     <li>",
"      Clinical success",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1506674571\">",
"    <span class=\"h1\">",
"     OCCUPATIONAL RISKS IN ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;During GI endoscopy, both patients and personnel are exposed to potential infectious, chemical, electrical, radiation, and mechanical hazards [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since ERCP is a technically complex endoscopic procedure, adverse events are more frequent in comparison with other endoscopic procedures, which likely also applies to the staff performing the procedure. Safety practices for protection of the endoscopic staff include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Personal protective equipment",
"     </li>",
"     <li>",
"      Radiation and electricity safety",
"     </li>",
"     <li>",
"      Optimizing ergonomics",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Attention must be paid to controlling infection, with special regard to the reprocessing of endoscopes and transmission of microorganisms by endoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/49/39705/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/9/30865?source=see_link\">",
"       \"Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A consensus development conference sponsored by the National Institutes of Health in 2002 developed a statement regarding the indications for endoscopic retrograde cholangiopancreatography (ERCP). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications for ERCP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of complications have been described, which can be categorized as nonspecific (eg, due to sedation or drug side effects) or specific (due to the procedure itself). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Specific complications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Nonspecific complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several risk factors for complications have been identified some of which may help identify patients who may be at increased risk. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Risk factors for overall complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The American Society for Gastrointestinal Endoscopy has identified a number of quality indicators that can be monitored to help assure that ERCP is performed safely. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Assuring good quality'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Young HS, Keeffe EB. Complications of gastrointestinal endoscopy. In: Sleisenger &amp; Fordtran's Gastrointestinal and Liver Disease, 6th ed, WB Saunders, Philadelphia 1998. p.301.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/2\">",
"      Jowell PS, Baillie J, Branch MS, et al. Quantitative assessment of procedural competence. A prospective study of training in endoscopic retrograde cholangiopancreatography. Ann Intern Med 1996; 125:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/3\">",
"      Huibregtse K. Complications of endoscopic sphincterotomy and their prevention. N Engl J Med 1996; 335:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/4\">",
"      Rabenstein T, Schneider HT, Nicklas M, et al. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc 1999; 50:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/5\">",
"      Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/6\">",
"      Cohen S, Bacon BR, Berlin JA, et al. National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 2002; 56:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/7\">",
"      Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 2005; 62:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/8\">",
"      Cotton PB. Analysis of 59 ERCP lawsuits; mainly about indications. Gastrointest Endosc 2006; 63:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/9\">",
"      Petrini JL Jr. Fools rush in ... Gastrointest Endosc 2006; 63:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/10\">",
"      Frakes JT. The ERCP-related lawsuit: \"Best avoid it!\". Gastrointest Endosc 2006; 63:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/11\">",
"      Trap R, Adamsen S, Hart-Hansen O, Henriksen M. Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 1999; 31:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/12\">",
"      Ferreira LE, Topazian MD, Harmsen WS, et al. Dietary approaches following endoscopic retrograde cholangiopancreatography: A survey of selected endoscopists. World J Gastrointest Endosc 2010; 2:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/13\">",
"      Gottlieb K, Sherman S, Pezzi J, et al. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol 1996; 91:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/14\">",
"      Ho KY, Montes H, Sossenheimer MJ, et al. Features that may predict hospital admission following outpatient therapeutic ERCP. Gastrointest Endosc 1999; 49:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/15\">",
"      Cotton PB. Outcomes of endoscopy procedures: struggling towards definitions. Gastrointest Endosc 1994; 40:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/16\">",
"      Fleischer DE. Better definition of endoscopic complications and other negative outcomes. Gastrointest Endosc 1994; 40:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/17\">",
"      Petersen BT. ERCP outcomes: defining the operators, experience, and environments. Gastrointest Endosc 2002; 55:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/18\">",
"      Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/19\">",
"      Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/20\">",
"      Mallery JS, Baron TH, Dominitz JA, et al. Complications of ERCP. Gastrointest Endosc 2003; 57:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/21\">",
"      Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/22\">",
"      Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102:1781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/23\">",
"      Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007; 39:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/24\">",
"      Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009; 104:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/25\">",
"      Kapral C, M&uuml;hlberger A, Wewalka F, et al. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Eur J Gastroenterol Hepatol 2012; 24:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/26\">",
"      Glomsaker T, Hoff G, Kval&oslash;y JT, et al. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg 2013; 100:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/27\">",
"      Aliperti G. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am 1996; 6:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/28\">",
"      Etzkorn KP, Diab F, Brown RD, et al. Endoscopic retrograde cholangiopancreatography under general anesthesia: indications and results. Gastrointest Endosc 1998; 47:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/29\">",
"      Graber RG. Propofol in the endoscopy suite: an anesthesiologist's perspective. Gastrointest Endosc 1999; 49:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/30\">",
"      Nelson DB, Barkun AN, Block KP, et al. Propofol use during gastrointestinal endoscopy. Gastrointest Endosc 2001; 53:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/31\">",
"      Faigel DO, Baron TH, Goldstein JL, et al. Guidelines for the use of deep sedation and anesthesia for GI endoscopy. Gastrointest Endosc 2002; 56:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/32\">",
"      Vargo JJ, Cohen LB, Rex DK, Kwo PY. Position statement: nonanesthesiologist administration of propofol for GI endoscopy. Gastrointest Endosc 2009; 70:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/33\">",
"      Dumonceau JM, Riphaus A, Aparicio JR, et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy 2010; 42:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/34\">",
"      Mishkin D, Carpenter S, Croffie J, et al. ASGE Technology Status Evaluation Report: radiographic contrast media used in ERCP. Gastrointest Endosc 2005; 62:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/35\">",
"      Draganov PV, Forsmark CE. Prospective evaluation of adverse reactions to iodine-containing contrast media after ERCP. Gastrointest Endosc 2008; 68:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/36\">",
"      Draganov P, Cotton PB. Iodinated contrast sensitivity in ERCP. Am J Gastroenterol 2000; 95:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/37\">",
"      Lawrence C, Cotton PB. Gadolinium as an alternative contrast agent for therapeutic ERCP in the iodine-allergic patient. Endoscopy 2009; 41:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/38\">",
"      Bell GD, McCloy RF, Charlton JE, et al. Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut 1991; 32:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/39\">",
"      Fisher L, Fisher A, Thomson A. Cardiopulmonary complications of ERCP in older patients. Gastrointest Endosc 2006; 63:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/40\">",
"      Cheng Y, Xiong XZ, Wu SJ, et al. Carbon dioxide insufflation for endoscopic retrograde cholangiopancreatography: A meta-analysis and systematic review. World J Gastroenterol 2012; 18:5622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/41\">",
"      Palazzo L, Girollet PP, Salmeron M, et al. Value of endoscopic ultrasonography in the diagnosis of common bile duct stones: comparison with surgical exploration and ERCP. Gastrointest Endosc 1995; 42:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/42\">",
"      Petersen BT, Hussain N, Marine JE, et al. Endoscopy in patients with implanted electronic devices. Gastrointest Endosc 2007; 65:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/43\">",
"      Soto JA, Barish MA, Yucel EK, et al. Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology 1996; 110:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/44\">",
"      Tanner AR. ERCP: present practice in a single region. Suggested standards for monitoring performance. Eur J Gastroenterol Hepatol 1996; 8:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/45\">",
"      Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/46\">",
"      Cotton PB, Garrow DA, Gallagher J, Romagnuolo J. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc 2009; 70:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/47\">",
"      Margulies C, Siqueira ES, Silverman WB, et al. The effect of endoscopic sphincterotomy on acute and chronic complications of biliary endoprostheses. Gastrointest Endosc 1999; 49:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/48\">",
"      Cotton PB. Precut papillotomy--a risky technique for experts only. Gastrointest Endosc 1989; 35:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/49\">",
"      Maldonado ME, Brady PG, Mamel JJ, Robinson B. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). Am J Gastroenterol 1999; 94:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/50\">",
"      Rabenstein T, Schneider HT, Hahn EG, Ell C. 25 years of endoscopic sphincterotomy in Erlangen: assessment of the experience in 3498 patients. Endoscopy 1998; 30:A194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/51\">",
"      Hawes RH, Cotton PB, Vallon AG. Follow-up 6 to 11 years after duodenoscopic sphincterotomy for stones in patients with prior cholecystectomy. Gastroenterology 1990; 98:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/52\">",
"      Prat F, Malak NA, Pelletier G, et al. Biliary symptoms and complications more than 8 years after endoscopic sphincterotomy for choledocholithiasis. Gastroenterology 1996; 110:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/53\">",
"      Sugiyama M, Atomi Y. Follow-up of more than 10 years after endoscopic sphincterotomy for choledocholithiasis in young patients. Br J Surg 1998; 85:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/54\">",
"      Veldkamp MC, Rauws EA, Dijkgraaf MG, et al. Iatrogenic ampullary stenosis: history, endoscopic management, and outcome in a series of 49 patients. Gastrointest Endosc 2007; 66:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/55\">",
"      Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/56\">",
"      Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004; 60:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/57\">",
"      Freeman ML. Adverse outcomes of ERCP. Gastrointest Endosc 2002; 56:S273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/58\">",
"      Rodr&iacute;guez-Gonz&aacute;lez FJ, Naranjo-Rodr&iacute;guez A, Mata-Tapia I, et al. ERCP in patients 90 years of age and older. Gastrointest Endosc 2003; 58:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/59\">",
"      Varadarajulu S, Kilgore ML, Wilcox CM, Eloubeidi MA. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc 2006; 64:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/60\">",
"      Johanson JF, Cooper G, Eisen GM, et al. Quality assessment of ERCP. Endoscopic retrograde cholangiopacreatography. Gastrointest Endosc 2002; 56:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/61\">",
"      Schutz SM, Abbott RM. Grading ERCPs by degree of difficulty: a new concept to produce more meaningful outcome data. Gastrointest Endosc 2000; 51:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/62\">",
"      ASGE Technology Committee, Pedrosa MC, Farraye FA, et al. Minimizing occupational hazards in endoscopy: personal protective equipment, radiation safety, and ergonomics. Gastrointest Endosc 2010; 72:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/63\">",
"      O'Sullivan S, Bridge G, Ponich T. Musculoskeletal injuries among ERCP endoscopists in Canada. Can J Gastroenterol 2002; 16:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/49/39705/abstract/64\">",
"      ASGE STANDARDS OF PRACTICE COMMITTEE, Banerjee S, Shen B, et al. Infection control during GI endoscopy. Gastrointest Endosc 2008; 67:781.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 632 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-CEC8CE9A1B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39705=[""].join("\n");
var outline_f38_49_39705=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS FOR ERCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      National Institutes of Health",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      American Society of Gastrointestinal Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84322493\">",
"      INFORMED CONSENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84322500\">",
"      MONITORING DURING AND AFTER ERCP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H84322341\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Definition and classification of complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Reporting complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Incidence rates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Specific complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Bleeding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Nonspecific complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Medication-related complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Anticholinergic side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Contrast allergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Oversedation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Cardiopulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H543587980\">",
"      Carbon dioxide insufflation versus air insufflation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Electrosurgical hazards",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Miscellaneous complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Diagnostic versus therapeutic ERCP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Sphincterotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Late complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Papillary stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Risk factors for overall complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      ASSURING GOOD QUALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1506674571\">",
"      OCCUPATIONAL RISKS IN ERCP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/632\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/632|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/46/20204\" title=\"table 1A\">",
"      Classes of ERCP complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/52/9036\" title=\"table 1B\">",
"      Grading of ERCP complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/60/13259\" title=\"table 2\">",
"      ASGE guideline personnel propaf",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/0/8205\" title=\"table 3\">",
"      Studies of ERCP complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/42/13997\" title=\"table 4\">",
"      Risk ERCP complications",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/2/43049?source=related_link\">",
"      Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/25/41367?source=related_link\">",
"      Antibiotic prophylaxis for gastrointestinal endoscopic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/41/28310?source=related_link\">",
"      Complications of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/23/22905?source=related_link\">",
"      Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/57/29591?source=related_link\">",
"      Endoscopic ultrasound in chronic pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/34/43557?source=related_link\">",
"      Endoscopic ultrasound in patients with suspected choledocholithiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/43/8884?source=related_link\">",
"      Endoscopic ultrasound: Normal pancreaticobiliary anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=related_link\">",
"      Overview of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/9/30865?source=related_link\">",
"      Patient information: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/38/26216?source=related_link\">",
"      Post-ERCP bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/63/28666?source=related_link\">",
"      Post-ERCP pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/38/20072?source=related_link\">",
"      Post-ERCP perforation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/25/23959?source=related_link\">",
"      Post-ERCP septic complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/10/25767?source=related_link\">",
"      Precut (access) papillotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/44/7882?source=related_link\">",
"      Rare complications of ERCP",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_49_39706="Cutaneous squamous cell carcinoma";
var content_f38_49_39706=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F60026%7EDERM%2F74240%7EDERM%2F52178%7EDERM%2F64981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F60026%7EDERM%2F74240%7EDERM%2F52178%7EDERM%2F64981&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cutaneous squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, hyperkeratotic papule is present on the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous papule with a keratotic cutaneous horn is present on the preauricular skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous scaly papule is present on the lower leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous squamous cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An erythematous, scaly papule is present on the dorsal hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39706=[""].join("\n");
var outline_f38_49_39706=null;
var title_f38_49_39707="Further laboratory testing for pediatric hyperkalemia";
var content_f38_49_39707=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F85976&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F85976&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Initial diagnostic studies to assess unexplained hyperkalemia in a child",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        In a child with no obvious risk factor for hyperkalemia and normal volume status, repeat testing of serum/plasma potassium from a free flowing venous sample to differentiate true significant hyperkalemia from pseudohyperkalemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        In a child with unexplained&nbsp;true hyperkalemia based on repeated testing:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Complete blood count, platelets, and serum lactic dehydrogenase (LDH) to assess for blood dyscrasia or hemolysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum creatine kinase (CK) to detect muscle injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blood electrolytes (sodium, potassium, bicarbonate, chloride) to detect other electrolyte abnormalities such as metabolic acidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum creatinine and blood urea nitrogen to assess renal function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urinalysis to detect renal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urine chemistries (urine should be obtained at same time or within a brief time of blood studies):",
"        <ul>",
"         <li>",
"          Urine potassium values should be greater than 20 mEq/L",
"         </li>",
"         <li>",
"          Urine sodium values less than 20 mEq/L suggest increased proximal sodium absorption and a decrease in sodium delivery in the distal tubule resulting in impaired potassium excretion due to limited availability of sodium for exchange",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        If there is a clinical concern for endocrinopathy, obtain serum aldosterone and plasma renin activity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39707=[""].join("\n");
var outline_f38_49_39707=null;
var title_f38_49_39708="Transudative pleural effusions";
var content_f38_49_39708=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F73530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F73530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of transudative pleural effusions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Causes of transudative effusions",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Processes that",
"        <em>",
"         always",
"        </em>",
"        cause a transudative effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Atelectasis",
"       </td>",
"       <td>",
"        Caused by increased intrapleural negative pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cerebrospinal fluid leak into pleural space",
"       </td>",
"       <td>",
"        Thoracic spinal surgery or trauma and ventriculopleural shunts",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Heart failure",
"       </td>",
"       <td>",
"        Acute diuresis can result in borderline exudative features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatic hydrothorax",
"       </td>",
"       <td>",
"        Rare without clinical ascites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypoalbuminemia",
"       </td>",
"       <td>",
"        Edema fluid rarely isolated to pleural space",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Iatrogenic",
"       </td>",
"       <td>",
"        Misplaced intravenous catheter into the pleural space; post Fontan procedure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nephrotic syndrome",
"       </td>",
"       <td>",
"        Usually subpulmonic and bilateral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Peritoneal dialysis",
"       </td>",
"       <td>",
"        Acute massive effusion develops within 48 hours of initiating dialysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urinothorax",
"       </td>",
"       <td>",
"        Caused by ipsilateral obstructive uropathy",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Processes that",
"        <em>",
"         may",
"        </em>",
"        cause a transudative effusion, but",
"        <em>",
"         usually",
"        </em>",
"        cause an exudative effusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Amyloidosis",
"       </td>",
"       <td>",
"        Often exudative due to disruption of pleural surfaces",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chylothorax",
"       </td>",
"       <td>",
"        Most are exudative effusions&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Constrictive pericarditis",
"       </td>",
"       <td>",
"        Bilateral effusions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypothyroid pleural effusion",
"       </td>",
"       <td>",
"        From hypothyroid heart disease or hypothyroidism per se",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malignancy",
"       </td>",
"       <td>",
"        Usually exudative, but 3 to 10 percent transudative possibly due to early lymphatic obstruction, obstructive atelectasis, or concomitant disease (eg, heart failure)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pulmonary embolism",
"       </td>",
"       <td>",
"        Most are exudative effusions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sarcoidosis",
"       </td>",
"       <td>",
"        Stage II and III disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Superior vena caval obstruction",
"       </td>",
"       <td>",
"        May be due to acute systemic venous hypertension or acute blockage of thoracic lymph flow",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trapped lung",
"       </td>",
"       <td>",
"        A result of remote or chronic inflammation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39708=[""].join("\n");
var outline_f38_49_39708=null;
var title_f38_49_39709="Benefit of LTOT in NOTT";
var content_f38_49_39709=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 498px\">",
"   <div class=\"ttl\">",
"    Survival benefit of continuous long-term oxygen therapy in COPD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 478px; height: 226px; background-image: url(data:image/gif;base64,R0lGODlh3gHiANUAAP///4CAgAAAAEBAQP8AAMDAwP+AgICZzP9AQAAzmf/AwDAwMHBwcBAQENDQ0KCgoP+goCAgICBNpv8QEPDw8KCz2f8gILCwsODg4JCQkEBms/9QUFBQUP/w8MDN5v/g4GBgYBBAn/9gYP8wMP+wsP9wcPDz+bDA3/+QkP/Q0HCNxpCm02CAv+Dm81BzudDZ7DBZrN+ms88ZLA8vj4CMpkBNZu/DyV8fX68wT4+Wwm8cVqCjyRA1ggAAAAAAAAAAACH5BAAAAAAALAAAAADeAeIAAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq9dBQ5EFwEZGEO1t7C8vb5FDgECA0MMAgsNDbjGyMq/z9CrAwLDQhQCDQAZAgzX2dsM0eLjlA64AOZJBdUA68Tu7u3VBQH19TQ7Nh3k/P2AAwGEBCCGJJ68d8PiKbRXrwaPBDdwIDBAIoW/ixjhOBjQIMIAjgSPGHRwDMAFARxILjCJ8ki9FiskzNAhwwIBBCJQKNiXsadP/zDrqFFrcAGJg20LClAAEEHABQ4CHjB1ClWqkXpDXqgIISFHDBQiEBCwMLHiz7NoqzCwqmSa0ALoFmALF3cuEqxFTrBIoKGCCQApSBhAYBOnzrSIExstwHiWGLxGTFTQkIDFCSIdFIAtXILEB8WgzxoTGhIMZCQwJYRQ8cJIB8EIJkzYYEBB6Nv9sNljazpgE61cV7RAkgKCiBEERoiAYBG3814RfJc53UQvX79KFBjYILssz+fgUTEYwFjWGOpOJLtI4AK7kg8kSoi1IMIABAU7w+v/5JZa6S/oQQETDCFY5oRm2yEgFgE3IUCbffh9t9+EjTzAEG8ASmfFgAVeJv9FZgpAYECCCzZIGwQUpmhILRgE4FgYAVahlQQSsLYFiCKOMIEBEqroox6jFcABCOdpuMWMNbbWhQIiECBCcz9GaUcDICQ1UJFi6BUCDMJ18UEJEyCAopRkxiFAAeSB8J8XMXahJZfD3QiBBRag0GOZeJoxwAIRQJUBUPUAdIZ61y0Zmwif5akoGQ40QM0CS31Bz0BGliEZjRV4KUKYti3qKVAvPlbpGRVg2kUHKNAJwZ2ftioFByth0MCoXLRpRqkSZNoFBLGVkKirwELhlBDjYQkHrrpykUKTInQa7LNKDAtAsaLOgawXHRgwwQgo/Artt0Jw0AADxvxZLR3XegH/AXf0kcAquJ460NQxkcJI6xvpeqEdciPUBm+w5pFhK76mgvGaCBbM1u2/in50xsDHFhzGByiwK4K7DEt5pRkQx5GvGPsm52/GKRrz0QB02fsHsnGOcXDCJ+LnLcmh9ceOyoBMlgCXSpJBMYkTMDiCgiWMiJ+zNKdYSwDnmGRL00V0bIcJWtbooRpHjygfAsgREKaDBiyctDgOyFVABOY2AcIxjsLFTDJQDyF1HjMW6F4cH+AnosUYj+1LMwVQ2wQ1FAgTgDfacOPSvYHARJkGXdoRcr9I+82KU+RtrLYAESwAqULzMERpI+ptaaMdLys8s+WmNJDBABdEQKQTSGHj/wDo74guKCQnqKCagXdQzPe7rHsizFtOkETMNgOoxBIHi1PywgEwsBe55AbwO3LxobzOQVFOYIDNBWsT2dRTUUVvSQsVuMCVZX+hTgLCs0GowOrcV0JBwE880BSVSymbXdSXCQ9Qb2cH8AAefrYBBQUtOUQzGn7y54gHCAVSxuIE1VigGhdcTw9ZM8DWuva1B43ohChMoQpLMCYKtqEjATDG7HAGCpi4TwLwI0TeQqTCHvpwRGSpnAvP0AC4TGtNXZjbJQxYPRgksBPaQtQQ0xBDxoCAA/xjE+M+scEOJgsTHdgUj6aoJ6GQhoaq4NAB4oeJFMSmhWQMg4VEh6Fabf+xFB7YCwt6dgkFWGAEQowjIZQoihZspS+aQMFs8CdIQBByFJeSwArYWIkOlIAAJSBeI/fwSDxqoEAtq8QHuIOCTQqik6ZoAQtCoAEF9nEEFgikKaXggAfUqzf8MEFMckXJSUAgTFCa5RTWMatbamFSu+vHZFYTSklkawIi0KQwlUCPZG4BmXf8xQv06EpKfECM07wDKl1hggNs6YuSUABh4BjOIpzsnSnD5Vk+Jok5WYCd7QSAGc94LrTQMxL2xGc+0TDOX/wTEgEdqDUysJsMJuagj0hoPqHCTzQqBqKOkOg0uXEma2boORhthEZNeSZlaE6eIJWYL1U1ywY8gAP/EWgAEu24n5AyYqRj+NmqpsCrYPbjAQ9oVANC9dEJ2XQROP0CBBjEIAQ8QSxC0A4jxWFMh9ZUpfVkKRg+4DXbpMAAALAkTizyAYrIB6x+JEBtpAoA+6AAJ/uwjxDkCoC3boAEcx2TXMU6kSKQoIGlrOsYUVAbf2nHIiTAyYii2sBMAkBEf92AT9uwJ1tOYWnn0EXc5JbN2+BqBd3MqgV+SFoUyhIFmCyCjrI3gbw1NWgQ+OVNREQA2wjNJiIAwE2EsNtLlmADBMDrbnXr1ISJ0AJEIAEBNuBbACjASUvt1nIBAFz4iMwmAFAuc6c7H+QgNw6jEQAIjNgECsjFc25j/5szrtJZ3LRPAnxRwQmaKdKilZa0sjSAWomQgtQqVyf7VS5YodrW2hI3rLsd7m63heANHPjAsqmPt4C7Dx0JAbWzEYJYuOrgDQMAqsAFIgE+PGIAIGcOFLjANGZ6hLWlDXHgIKCUqHaAT4bABU90xVKdKgTXolWtz/3xgEusX9vyOMFHdqqClZxkwGzAJq0dAoEJzFUCjGmpyMHrlEcsFhSSWMMl1ggD5jVDJjhqGgvAAO7aobv2TugFFWBBE1lQAT6eojAJAsAEYgncFATZufsVS0WK/OAFY7JJTgWuYAhQyqCVANEfvo9YoIRaiky3AzqKjUU6ELQJCOGSFMEuav83oID5ffnUcJhGBBhA1CVQowDlW/Ok7OHRTxnQfaw8wAl6GYpRMqhOgPEuiv78ZxIEjbAGXvJjZXNJp3YAuBMogRB+Ge3dAncs7ATTcvfRpJ1si9upDet8sNtWm3C3xASGQwbAFwVHHcR5J4Eee+HVgt5RRgIuuBrNkJOoD9znlyPwg1JuV55WJ2FtAUD4VNBXRwAUVEoeWMGNeQ2u/vIYMA+UrB86akYWG4ECFKWLAMd1Fzd/ygQukEBoFboGps2xHg2nqd9OsBqKdyKxAuUpAiZ7BD8nd0Qz6ykY3Fg5+Tjh2Q6+ZlUtSrMWaEDlouD0xbFA6PfIdghN0pGBh1D/dS9sqkfpZkJ/waqFaYCA3f20nMRVEAr9JgqyG9D4YxUUWF45CK9lLTVtFfBV2xyWCPpl0BAYlK39cp3RYcErYMLiWLZKNe8kQNFfcdIpTudWCIl98oi/SbQOZAtFZVX817XwALlwLm0oZZ3TYWBnTQxNymPxLgB8C9xSMtcANnFt0CZSWw5TlwCrE7wQmvTHEUhIv2Fi0Ac+sC1tBZzQRX7u7pdKG9pMmwDNUW6/sKtOAzALAAmrq5WjGlwubORmqS/eChJwAE8Y/tQn3vOIdltWwtT2udIusG02PF0jCF/8yDEBwURol6QZ5XdJX2Vg0RduqNUvLTQCAScE1XVq/8YhFk6lXyRgYYNHdlhQekOBekVFQS8AA6zHCe+3Zbo1WiMCAcw3AsZxf4ZHaFhWfv5XYhYnflMHfbWlg9qhgDDIgYPBINLGVYF1alDlW8/lVFyFHPnHWxx4BWaHdkzHPQeQACuwCRaQdEY4YiHGQ89FamKBHzFoYJzmNUbgWr3HVRMwP04CeD7Id8vlR57WgLj3gxdWAiEyXZf0HfoValwWXDsGZtg3BP2Vc1KgFA9jcgwzghpAX5MwelsYVpviNWDVJNtih/o3fOHmhkwFVnPiNdHkhrYhgzYxApsmFiMAXGJIdiRgbhuwD9CEGeM2Yimwe8OFZW44VVHgMByjiP8ZsxVXeAlc1YRdwG93sFSytASX1EKWtwUnZVVT5AES0IiXoF+GWAU3eAeCQQWywROYNgHSBAUm8xHxFIKCZAJboW8sxwU243FZ8HAMI40uYHPruAfYNE0oFwIHsI/82I/++I/7eDf1+HIBEHNYcI/h1DsAuZAASRnAs47tCI312ASpsRqtN00EVwAuJZET6QTAIUmOOE0DIG9T2JFQYB19QY9TNEcmw5EmCQWS4ZDqOAYe4AF/YQIeEJJkMBkXyR9mJIVa9JJaUJGnMwYJwB4A4AHs5wSUwQVVuHKhkJGbFZRCeSRbAZJicJQJUJNLCQAroAH5JgS6pAGQI43sV5P/BzAcBtQCLZBAJ1ABBqQXGuAhKkCWewQAT1kEXxmW03MZfXkCaQkAFbBGeKkBKnAAujIZkCMEiPmVLKCScMAALtIRSydzVckFKMmQmtmPUDkEO8MVJ7CUKpAAKrAel0EZKrAVFRAC15GXT6mUrKkBVchKRzkcEnAAV4mXW0kEo1maCXCaIeABMCABkmGFAMAVADCaOMYXyUma63GFRzmclaEHLiUuJJd2l7kFkrGZ3NmZQnAdfLGUWwIAJsAeLzCdADAcTambCvSapMmYuzmaCuQBdcma7EkE41meLkCeqpEArWECWxKa0CkB36kBx3mbVWigzFmeBpoHZ9Inz0iV/9n5B8xJGUvJnADAF0rZfkOwnq65lRsKn+25laGZb9Vzn57ZoBi6FwQqBHtRPX+BocyZAAiKmBmqog2KB30iADHkjlgAjxOKBsyplEtpmlV4hSEQAidwAjAAAJRxAi+wfk4EX1zJoR9qQOx3AvCFokJgpMZZAeyBnkS6nwBQPW/JnOuRQIN5owWqB9ugDKvmkkFqByu6lCiXAKshBC+wHsxJc1ZoApQBA+tRpSLKniZQPTSSAFxKnuuRpy/ASrqpK/DlIS8AX49DnquEp+0nozmKB+awP5WZBGr2IppVcnOaFuXZokl5AljKdp1gXuzwNusVNb54qr2wfhwqmEdZIP+QOQmjQQwwpjjzZqvECgXrIAwIkaxsxhC1VqwmCaqIWF6rJmuhw6y16qyNZEFnsgDlqA771DwlEW8yhq0d2TkRUE1OsD8FgBSzcD5VMa7kWo8dFTg+WgQjIRfXOazxWq5VEgD5mn77ynInMRRTaZkBW4/BsAtyerDCtG6JyLD1qGoMULAGC7H55AAMYHplZo4Wm08U8AArtrAdK0jhhUUiO7JkVFmhWrEoO0srK6Eta0rNMx4n061JdK0xSzIcV1GxECg4m7PZiZBAK7O+wQAkCbBDO0Qt4hH1sAD1agVAmrTPEhRm9LNMELVSCyz7swDjlUVIm7UBi7Vg6yoP4Cj//nGyY5s0EdAUHLGxMJu2FOQUAjAtbnuzcDtF2xoAHPC0VSC2d6soXHs8Nsuyf8s9GQCCHFu4A/Wx9dA0pQqviksz+3S2TnA82LAM6jWVfhu5P/JONfsEBYALUHE42JA4Nru5nEsza/MAstZmqcs6EQkFztO61vq6lkOz0zC4SFC2GARvLaGvtms5C9BebyqZUuGu6QO8wZs0FOARTxCRIze4qLu8+2EzdUu41PstuAsCL/ujVpu9jTS94PscFMBQMIe246so80K5JZm+roISBYe+7lsmDHC9iTu/ZNtx8ou/UYINn4ud/Nsq0fGwARwsY9ZQAFzAixK7XiC0Cvwp/xnptdfksw/sKhFscNhbwWTCwF+rwVLycgKAuHbrwa4yAParBeJLwhlBcBcgU/urws9hM9+rBCkMw/7wcgbpjDNswz6xP+egZt17BTXMw+KwDY5BEiKcwUQcHntCBE77wkuMGE08BE+cwFEcHi4mBNtwwu+4w1fcD7KyTxhcXhZiWab6xSniABSVFFYgF2iWBEOMxrghrlABlALhxXI8IYbjcDwqBLMWKAAhOoI8yIRcyIZ8yIicyIq8yIzcyI78yJAcyZI8yfVAXkO0x3u8rLQWyI78EZHsyY8MyqHMyY0syp1MyoxsyqWMyousyqnMyorsyq2Mx54SY+VyxlIwTv+opMu1ystU4MtTAMy5fK1xHCXic65NUbC7TMy9zMy/7MzBDM3D3LfNTM2C5D+cY5CoxBjWPEyWHAXb/M1QEM7dfIji/ATk/Mz1WMy02nK03ATsTATxzFnuvM7vfLX3vATzfMf1rAb77HD5/C/crAYDnQYFjQYHfQYJbQYLXQYNnccQHdESPdFxxLhmfAaMG9D2+iIYwFAZEMRWwD+M+9Fh0NG2cEu3Q7FYcBQFGSkWDdJTwNIXndHh5MYlcQaNMgwRUAbBcDP9sRJg0NMEAavT0AAwvYsXNAQ5nc/6CwA2DdRf0NQ5PQA7LUx0LC1l0BRj7AVuERIXQAHNeyZg0NX/flwS03DOWfDVYW1EppfPUiE+c3vVdpwFb00NQqDV7YTJfczTnNMURysGBkEEyRwGBgGrfMLFWTDY/moMAR04fazX+ezYAUESa/u7swTZDH0MBSAXOXxN6Ge6gM0OFAACHUEvYhBjJFELew0GIKs4mM3auSsPScHZDas4t8zXxJDJYxDY0yJeu80O2xAQoxsGMiQQ+6TRZ23LITwGZ608fKzRnnLMZyMAKt0F52M2jIIUiAgV0REAaL3S2v2xmk3bX8DdlaxmsCZe1U0Fmx1D1IAB0j3YDTy8o4EL1y3WwoTNEdDZXTBy/J0FNgMXxz3WZuQ2jjLAYDDgxn3PGGB6/xEAPvr931PQ4NTw4ELg3xSd4Rq+4Rze4R7+4SAe4jTDGJGS0jE9ABJ+BKONMmogOFDA4lEAslst4lpADX8C1+0lDHBxrFWwNmuh42cwDcEs4ULOZutN41dQ4b29194DPgX5OtyLAWbHutwwHr7hAGrCAbwhJB/xJ9Pt3VMOABigJiAwCxbS0U3TIgVwAVJBs2XOZuQDO0KgYjA1tyaxt+ZCD0/BAYWD4gIhFaLTDns7AF7eFN5ND7hAAePx5i1yAVaO5FXAOU5R2gFhDEY7LI/SFGXeFNwaFBwRFeIzvFckzyAwEFFRtsOAzdwqK8ObDABQ1PgtD2fGFDHUEXwsU//vfRLD2xTPY+m3jq/IQN36RAwfga8OV+rTAFRnZiFijQwBgAxq5h+OkuKQTgTDYJ173AArcQ3QUw3XkNtizeMn4SKcwwAkPQTlCyt9XORAvsWmjiYCYEzrkDL06m5AbgxCIuxCDhVLgQx8LODgDvBUPFQAkO5yERDsfiYkEQ4nkQHivtrV/gTDcBKS2cfsUA0XH/DyEBDi/ulQ7dSuE9yvbudALgyl3rhFTgQ8/jwXIBf//u9FLuQxP7dAXg01TxBr4xjIcLjrTvJnwuPHCvQQH/GD8w6F08d1LAx/kvHPzRh9HPRnp5HZMAScI9kjv+CycAwXEDjnZwQrbzixQ/OSYq3jYM/rwS2uN//y1RBrAn6ujD3yF9DTcNER+X47Tz/0RO9qIbHHIDdATI8Bfi30TGN6CxAq2joNCG/ngN8SLf8oUm7nKr/XsFrZL6/jFKBqvD4tjsLnaq/xGG9GAHD4fdzCIQzkArTfG5/6eb/6rN/6rv/6sB/7sj/7tF/7tn/7uJ/7ur/7vN/7vv/7wE8GQQAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The Nocturnal Oxygen Therapy Trial randomly assigned 203 patients with chronic obstructive pulmonary disease complicated by hypoxemia to treatment with nearly continuous oxygen therapy (red line) or nocturnal oxygen alone (blue line). Continuous oxygen therapy was associated with a significant survival benefit (p = 0.01).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from Nocturnal Oxygen Trial Therapy Group, Ann Intern Med 1980; 93:391.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39709=[""].join("\n");
var outline_f38_49_39709=null;
var title_f38_49_39710="Approach to generalized adenopathy in children";
var content_f38_49_39710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52799&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Suggested approach to generalized adenopathy in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 420px; background-image: url(data:image/gif;base64,R0lGODlh4QGkAcQAAP///wAAAIiIiERERLu7uyIiIt3d3ZmZmWZmZjMzMxEREe7u7szMzFVVVXd3d6qqqs/Pzz8/P5+fn9/f3+/v719fXw8PD39/f7+/vx8fH4+PjwAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADhAaQBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDOQGGh4iJiouMjY6PkJGSk5SViISYmTUBmlScnaChKJ+iTqSlqJ2nqUmrrK+ArrBEsrO2eLW3P7m6vXC8PwMCMgIDLsJDxT0BBKO+z3WuAgqGCQc9yMwvyi3IPtzcNNnNANonwNDpZqsCBeQOCNjDMeEr3j3gxjjm5ibo6gDDrFJwrYQAQwUYlEtg6BqBAg0BCBtQAMGha+MsIgRwMEBCjof0iTBwKMECAA0O/w3rmJBAAIYKFBKgRlAiwwDxDhxCQNIQgnYQTSLQN8DBiAcKSDAIsECYxgAkbxYc8S+gVS6nSDbriIBBTAAOGpRbWQBATaQ2DZBAkEDiMHMGChzwqjDs0q0iSZB80E6tMLpgG7hsNiCegmEHFDQVu1ShCJ0LwBUwsIAgSQOXRywIwODAZAFix4kIQLZE1auorwycigCBzkNltXnueciAt2kbRXu99hqhZxH1GAy42FqEsN4eXYponbmc7XkBDhy4CTWfCLlu4ZVIIMAaggbDRJdr9pvE6dTopaxyUBNl169UyZdtb3zYXrBlx3klB1hEY5R5sQXAZge0s8ACBQjQH/8AygFQ3GEcKYbMA1AVYBSFBnQHnD7YPQTfCNMY9lU2D4wmn2nppdiFNNS8dE1HOI0HwG8P5TbPcB7l9xYBOBoCkk8OVpPXTB5FtwBMCf6IU4PFEVlTjyshBJVXOHGDHQAJ5OWfNg6U5VaQUMnmJVUqlpnFeXLcI0Nl5Cxj5ptVoBmHmjE40NYucOYZhZxw8qnnnzr4aaaggBZKA6HLtOlDg0l0tImhkBaBaA3i9dMCoyxgKqNpit6wWacxTBrpqCmIagM/oKqgqar/WHrDUjeYSuqsZNbgJEbFjInWCEs1JcBTUUV0KwBJXgaRR2tdRIJLMCnEDAM3NQBsRwk469n/cM24dNIIOA6AIJCH0ipuITZAmFhTCailGWezgfYlP6WZq1ixUK06goAjDCZRPMxoGB8A/w1VjlgOxlMciAUcyJ29MMg67qiCNgcVnVh2d8B34e1o4oyTQTVaXPbVy+JG+X5SHDMGpGSNjOU9tOlMzS0XD0cIMPyCww9DSiiE0/hqQohmjfhWiSzPt5KE8RxkgLZ6BVBil8uazG+b7ZRT4n8NGNPPAAkQjPCBCdrsAs45F0rosBTfhV99YGrFMYM0OVQNVEciyy1CYzIo9XgwXqNRhtU42yaFoHa7gNgtkF32n4rXUU8QjS/epy0GKED0EJFLPujimWuuYufPgO45/3qyxEVaEIgz8bgJFN+QN4qjx27eCQ5ouWjkylnHwupf9p4DdxXNDLvssssC3hCp48C7Crx703oNFs3jD/HEu9JbytUs8J1xDhhwU9LCeExCO9SYxGwAXx37UXQFYKs3ukB6fwgBLtH2kzEOHOKYQcbUGF1vB+AakHoDPqWlxBACOBdH2sIdBRxseNTznCyQ0Z2TLGxKUJEWACrHgHakykAIEoC+CkMCCw1MZgWTSP8yeCdm5E4fynAa84xxlqQ4b4XqmhFTPBghvwwDO1ciVqkiGLsJDuMpMRKGdo7VkOVxozBMQoD2dvIyBWQGGcYqiAs5YZ124GRb/KONIZ7Dtv/LTKc23DgYBQfwgNcNkYgSPAEFTUKCxCigGRoEkTHUpscNEiSKkMHS1LjVtTJmkDFbXOCGSFATCPWRPhIxypeMdaHqwDBhIRyQArgzNjjGkXXzOGB0rqMP+Y1RGY+DkViiaMqKbAoAhDOkARgAEYjQjxNUul9lsucVMHKkf+rTYXSwWB0pZUgfdfPIPNjjSxWIzpOh+0ECOrU8F1STV+JrgQOkJwQEFeR554Cm5J55zRVU7nImcAkC42QIfVComc4UJ+fmKc+cPVMX96znLPJpC37qkxX+hEVA/1mKgQKUoOKyhEIXytCGOvShjkCoRKdg0Ila9BcXzSg0KqrRjp7/gaMeDakYQCrSkq7IpCgFBUlTylIoQCADGqBAACiggQxAoKU41UMEAmABngYgAjkN6h0kkAgJCPWodMjAITKA1KbG4QKHuIBTp9oGmRqCAlTNqhoqEIAKaPWrZ8BAADAA1rKSwatmTata18rWtqYConCNq1znOgm39mKlgsCrXUc6K73uFQx+/UNg/3pSUg2WsFs4LB8Ui1gsoMNVMzxD8pSnJcY21grSOEQD3GZN210HEbYpiQGQsi2S7I9XNwlbjPSGANKOhDMraNBkWbWCx1n2sp4oQZcUYht9dRYFQdyXJofRHn/pxYHAEYwhTmIRwxTEuCmQrehsi9u3lsBy/6aRyga/t11DgMcYnlFUcEnIQbBwiJvAuVPJhFGZBMSjdtdBr3Ha+a3kvAR9CmGJtVy5HIIV5YUHIeAvIVhdlZomh6MpjQY5mDU9TgfBxAJtj1bWq5nA81clcIlnfkXCCivmZ5i8oAhG+J66iCUAXhsxBpfGRXfUcYeVLXBBrzuVjf2GieybCm7QeZ0akxAkFvyV8Mb3uvpBRDgz484D1zKzX0lXZsiJTeEEoJ0XPoY6xySwjDOxHhf3VkzuIUGD06uTTo23yR8mHx7zUjmCgaZ+yvixmgFEZLCJkCl6k9mCXjkCO2aLixyqZJZnt2UDl+ApPAGzKaFiyu/qsMY4Dv+tb0SwGS/dMcM3uWAOf1xpEVyaBIarmzv2BqNBmqB9Kh7wjyAy6FoVWhOKfYBnZyDrwr6ay329NaxzrWtM3BYXvfY1r4Od1y48uZxj+DWxjfBrTSGbr8sOxK/VV7+d+A9XFEnMOrESbWkb+xNWNss10MI1v0jSC8ruthCaDW5AbzARZGQQQwZw2jOpW7DfPknu7gRJOuUxsff2w69FrZxc+k9H8/VIvR0b8D6kOxoNX+ywIw5sw1JcDw+nQ8Yvvo+Jc1zjHv+4HDY+cpHbgeRxQLnJQxXylbvBVOA8qMtLTowWNeAkanLirDUjSqMggmDQQoh8P1uboLtIIpplnmb/aTkPtmxGJTNQ+cwTJwMKXcN7oeHms1GQADoSoC2jdAkDKtfkFJewxgmQJIbJi13afaS3jUGKWkb5ThlIfeorkFMDzt0rAeLEfgKOM3ex2Uy6Jwy6KQhulkrQYdieoO3jS0ABiDbKaUQd7xiNQZJeaxtEdlBLkIkzDvPlxp93cMiJBy0DNEJvpKNv6B87h3pLkioW3B3zzojB3gnvjehw44ynNAYxc7gUCI8SJcBrQXDX0pbCHOncJoCkCOy0+eh4hcedxH0b5KSTqxdyQtW5kwkxFOeQIbjravl6OQqStTYnl85nJ8HKHCT8eFTuRR8eQZea0VsMYWj9sPQhN6N9/9s3A7iBYjgHdbnEEpY0Sdm0QTiiAD5XEjKRacRlZqCVP9XgFzMzGMdzaDsBMsthEsfXFyxHgGtwe0exczBQGfAkKSiYgi0Xg8k2gzQoEDZ4g1+ggjKog+uQgz7IbRYXhGTAg2pghCiIhGighNrHhD9IhDU4hFCIg1I4hTsIhFaIWViYhbl1BTGXeVxoa08AJb5DDEmnTi+BGYgAfU/ghJi3UiQkdl/IPGUBMvUjEZvlMV9ndk3ghngHhzNDEMigPvmlP9dGZCIgLXfYF+LTK3sShugmBSSkE/F2HQ7AR+IWgIi4G/VzJImWQ5C1BH44dXCoLOyFaOXxbqAFIlSEhv8m0RyOCAWjOHOACGoJhGfuhYnSBxx5c4ecJ2+o14eQKIZO8GP10UpJY4jBhDBRk0NiBHuiOIxCCDHSCHBVWI1aeI3Y2IXUuI2qsYXeqASzSIXhyI2RMo4rR1fquI7s+FDleBXo+I63EI/yuE/16FT0eI8yp49ClY/8OGP/KIrtOJAEWZAGeZAImZD+iHEJRSsLmQcPaY3a+E8RqQUVyXAWdZEYOZH6pJHfCI5E5JHZyJGeNAE3VQ4iAAET0I2GYpKjkZIrKU8yFQFEJQE7hVXnGCkzWZM3qU9chQholZOR8pOHEJTyBAGJcJJCCSlIiQhKWU87ZQhARZJ5EpU/hVD/RGUIRkWVcJKVAbCVBNVTFuCQsyKWEwVVUgWSKoKWEzUBARCTXAknbgmXCEVWZDkrdhmQ4qiXOSWSCaWQgBmYBBmF6yCYhnmYlBAu1ENyt+eXH2l3EcSYS2hPilk9hFkGjjmSJ2iZ0PaE4+InmQlYl1mElHl5rBKKe4CaMZBzLDg9nYmZKjAcIsE7WxdZQjBbwQCNrgmZBgEknPQCc+gCuLk7rZk4oDKcrNkwozmateFafVQyqmYDtRkqf4YElhKcL2ma/ONptYcC2KkE0zkK3QkDyTmAr0manBKdi/QzxUmcQKANwykP5smb26kReQMjauMSfUMtCuF38XCI/pln/wKmbadDSPFzE91DRayocC5RIu51PutDALRhPi0WFCehXygBdQhTPtpDFGyIkue5nCijLLxooVb2FNiWN4SoJMAUEQFqSkYBoQpBiCh6XzGhQIg3YsciADDKEQVgoUZ3YngEdRjKPkMGmifADZaCicVRHMgQMMLneTWkQnrDYi/WFB9KpfXTAIxxR48DGGERgA0mdighpCOwF7kzGZUxF18RFiaYc5iUIJcRM64mmh/lD3hhEGr6R+52L82XLsB1idqgDFM6ADjEpQBzR2SKqCNgQvCpDSQERDU2Ao5UpolKAH2xptDVL5PhFmB6YnyIpOy5MX3Wi1bkMcjQMgi3fv/wNnzKAXz1Mm+nNXxXMgAFAnqI4CUWoW+fUDXP0iMHEG5yEWVqpHVEEQ9KFIwgSo6wmZ6pxCHB6m4HuKqagYpeUgxiNDHmV6vRyotTBCSPikLF0EYnEDPcaiUHgD0rwwzFGmV8lp30OT76sKTXWUiRBDCw1WDgd3+2+G5WOn7Z9G8OmDKIhKnq5R8C2EaGmmeCNB4CQiDCyqb7A0Kbt0j86iELt6x26pn/8qw99kL3ATV0Eki5mK805GPmh6h30SDuRbL8UiJRpEmc1DOMJD0q2y/Qyoycamd7BlmiOj7gSk36A0vm8BoFEjiudzoHN7C5Y0w48hHcYn49mktA6xP/YocgNSNa40EkENGt6KokUoQkWpd0IrB44RSi54lGWoKuVva01DoSqWUwQsIgwTR8PeqKmBG3YKITKAQWH/aB+dIiPIqgqiYXfTMedaMASVJq76qxynkDz/adUhCfO8Amuces6GkGlBu1mvSCTPCzNHBO3aCbV7C5OWAnb4S5yykGplt3mvm4nKm6aMuSm1k8qyu7tAu7RhCeKSC5u9ueHTe7G1sFlKua1GkKlZkD5cS73km6RVCemHO7w+sE9cAwNmO8DTOepOoDoFsEzCtHzguewBsr0nuFpVsL16u9N6O+65a8MpAklcEXwpcrKKqeQZqhL3E4zOB7SEtBSAsj/wPgNkyTYTvao0CRv01hCDYUJe20avvFL+EbT8JrvjVwvytqpP4zuIZgFMrgP7WgPnybQvcVdseSoo0WwidDGPR1v88SLTvQvfRQFlUjeAgmIPVgXBVUMfqJrwohMH8BW0OxFCWiDE2qrJWqsl66p9EKRj+MF596QglGvhMcidJ5sI3qcwRzxF2KqTQ0DNb7CSgMwRGSieQGqGOmQyi0s0ciAJtqsNzrvjHAJitTfsDRIjLMZipzMYiQtY/hJS5zHH4sF9faP6cKYf7aqN90qz0GFq/nFuVRDO6KvbVLwc1aA+p6AN8aI9pgromMrXqIvmC8N4+arfEWRGHssE3GE/95PB6X/MJwHAMIUABpNr/v9jR3nKQJQkepxsN09sMKkTVYQxSFhIlmYbMF+7Vb8hzB3LNtUqCPMsXEWAPt4LKbosX4ysXFDBKexk1MUz/eM0hQ02+hJBLe7F58E6fS46tUI8P598zxOgMkMQ907Ho/qp6HK0rdChz9y8DVAiaoRrR5uiyCa8DQiobIekRzy7j94MyvPI2VTAN9g4xVhEAELUwMkai+JGpIt0n8ghDZUrfz0Ggbbc6QSl+H2y/KArjuPMlskEfcME1pIJl3qgXbFAYuGLzvnAY4AqiiywYyzbF3mdOfhLvTq5aEFrtFDc2AAsNDndREnQT2YrrpScn/ultE5UvFP+CLAhNdsoApm5tI0Zx9SE3VV20DWs2CUW0qkmyOVT06P/3QPXDWcIM+DsFE3WUItwQwquWjQOrCZ0odeU2gw3BAJjGggou/uown2mm7Si2Rt4MIXTwjigEhytEALXRLtFSdmUoQOQp/iVQUIEJHv6lDWBraQQY5DT1OZe3QcS0+QyExmaEcV7JFEphq6NrKiGwiyvF1AUBvSOQaWMbbvr3HqL3YVt3YFok6rh3ZPcMznHCztzQTXtynQVQ1IwDdmCItOWyJRJtD2p3YxS3UmvPWmXs76iIww/IaF01LRZLXXsHH6Hq4vBIUn40Qv3wRDChpH4HP4c3S/01N1sidBMUncKlNT0+N1ZOroQ5X4GVD3qvNOAw+C07WOQ4e4JNj3HKktXFQTjHnDpqy1vPp1CKuMxFOQpURwXMCjS4j1VRn4Y/ZkBjOOvb3FWjDXaaEekWCE9Wgivk7GNGBwXFTMWIGfYSYwOhjE0BSfhSBogB0iA4y3QwRoa7nLTJq5Kf6Z75U4QduNiVeEtcgL01xqDN+WqcTy2rYJmhaoCi2zZK9AGFKQgJ4xQOMhzxMw8zXO1O6Gbz6y0IKQhfE53NexFoW1gKBmIZ+6ItQ4k3GGeKjrf6KYzU2qPNKAMJxEYyyyY0+WpydALtCaYjGyBDSe4p8G3bsgKDlLv8Mq84HM+G8COpeXMiDztoXhw5yNtlH4zOXIbDmEdDs2hYQSwrmwDMfpgBWNA0pRs3JvK90HLL5IUmQxOm7TNKYis4sKzwDzjWh+uDLRuuw4RBBbrdYtuuq5kLU0LWXTg7DQmcEohdxa9BJuxK0TM9lYbQH5xUls4EyYjh46+4AvZsjfm8X6bsp4ABZGlvAwDta3nABj+JZzQs9HeuOzXGhCeCyTnETj+AUr/CRqe3EdvGEHvGzvvEurmuIXvImH1Ejz5cUqfIt5fEsf3Ivn1IuH/NzMPM0n3I3X1I2n/Mvx/MhtfM+fwYuCaIqGfQEtZNf2ZNG/09EaQhGufRHmZT/UE9QVjmVU69PXgmWV19PZrn1/8SWXq9Pcxn2/5SXZH/2aJ/26XDybN/2PqL28DrWaA/0G6n2dP/iaX/3rzv3IQn3cc/YcM8LsnkO7Es6fu+4zdnOnMLizYs8A6VzIZ73eKqeUy3h4yvBgY+ntDEVixbYVNT55/MV/GnlbkH6JaNhRXosGtEWE6q/fJ2/93svBW2jMlHA3DURexx4wjd4Z5v5zqolYwbWj8EUlq3bkNoVQDwAcy4Mc14yw/DEZT4ZnFXLaUoZm34CWy0XJJbNiTjm5Ub5oSd8o9f7dj/5jzPbgY1l6A9IgezqX5I/lcqwkczrlA6sEYvbyzH7MmOu/4gAAscgAIAwlEcSsMYJjIARGKVtB7e+873/A4PCIbFoPCKTyiWzmczpAgQT6tZoABhSQq7gADxo1+wWikBoGYBGlWyIlbS1EjeuUOOmL4AUkQAsBBzU7RUc2AgU3CQCECgMmiEAKJCUNEjawAn8AXiB0bzEzNSwRTmdoqaqrrK2ur4iQeG07NkwFASsEBCy4BrcBuDuRpqwJDBwsUiOJAdg0skKsDjz6VVtKQQLElYZSrMc2hjgJjzWAZw1ZgcIGKy0wDFkI3z7hpKMTk7dyML6/wMMKHAgQRyv5BRM6OpBG4MKH0KMKHFiqn6omlWiqLGJxY0eP4IM+aqjyJIESf+aTKlyZUqULF9WhClzJs2ELlXWqhlLJ8+ePjnqzJlzUUOeN38iTYr0qEmhRZU6hCp1qtGXjgI8MlEg27FpCA54pQLjHSZpMJlSTat2I1qNlAAcULAg0YIFBQQMBTsXxQAUXGqYfdl2LeHCJ1nm4+OiygB6VVRMWwwDHw2agw1jztzqssS3AuS+MPBoUwlPYSSLqhyYJWfNrl8raQ3xatZvAbDIc1YPFF/KgGVDBA57OHEfwosHR658uZHjzA8/jy6d33STzqtjV3o9u6vt3L/X9A4+5vjyhsWbB5p+PVX07J+8j5/Uvfwi9OvjH3g/P5D9/P93B2BA/glY4CkEGlj/AoIJMnjEggY+2KCEQUQoYIUTYrjDhf9tmKGHHeYHoocTilhfiSMyeCJRN5yDChxKvKjDOOw0MVQPKqJYYFsOCFKCNFh0UkkYzxSREzeTKbiPETHuYKMOTNrgwFNJOKlhjlcGGMQCCvTlowJZ3VVCX3IdYWQ/UC6ZURJorqHmElWagqWc5AERVz6JfGYXZbeEwwMuwahhm19/5nACWOBIAQMLAyzAxzuHIDDNITGGueUD9wxQQKTgILnDoYIQkwunBBAKV1hwUjenquoBMcAXMdClAAJhkoZqaQ5oYc0kJBwJhxR0LZAACTQyYoMfnfqoCCOhJDBHCceyGQNYz0pC/6wiCnzRoql7CYHjqvIxNcM0yirLAgmEVrbDAps6c4AiVOTTayV9lFXtFO6asI4iMW5JQAKH3ONlL8g+ScK06NgLVwHx5gAZLVNa+a3EDgZBGiAKXPouLgJw0SgMX5Rig14AJIBGAGqU4lmhfH1RDbBhJuruDA8A4MC+bs5KZsAz13xzvh6LySsN7iSMr8qdfHHaC7kaN7HTRDAV5rMNFAuWAAgACZcC+tzgTi+SbJoACoeuINahYE0xwKKNxrxvLz53TaNYcKgdjM9UFywmViVXo7Cp2hSjjWSoevu0ef4xBNWWQCtRbA8JKMlD4YaPN3lh3ygQOcWUcx5x5zd+Hv86H6JLTnrnIrLZJMSbaQ6S5aY/h7qbOuxhqyqJWgc75bL/UPvqrOBe0uu6K4fep5IkQk6jDUyjptcBOCCubgUov4YxC3DBRZ9xmWt9LthLIcg3x/RdN6PesxNXoxanEBb3ch9I/NP36ZWIAVseYD/BY8hDQO0L428TjRIWF9zkKkQkYIAco1Ea0IGCXxWgLsL6TA1iYIhO9OkGejngKoYnP+IY7x28Kc0B0kGwC8Igf1UoRAmn4Qxt0WEFA2AAu14IBXw1QhH08tEZMAGrATzgXSIToQH8FYAZ0umDq0KPaUaIwZepiX+/4gQLBWgDGFqBHgm8IhQaWAoI1uUuULz/mLB00ERnXSKJSpwTenYjGQwGCytSK8HzvpAbx5AQfZDYQd0KgDJJtWh8akiU+STYi0o4gEyL6AUN+oiH+K1xieWxSzhS5w8PRlIzmPzINKoQBsbpJ5Oq2mR2SClKwpiyOqk8ZVpW6QNLHkFaLGidRlzJSqlsEot5C55xaHmDGKyDE6675ZVsyQNY8sOXmSBBMEViTGIuJSSEoN730DesKTAPK53oBQ0jk80tZpNGh1KmRJ4JTZ/kslAAHM3CkARBZ9nAE4my4gTbiUyKmPOcVQHJkTBowhjssATrCkuiatjDoK0kn/oMjzRXRsIxvrN9A6wWzayYrDDOLiQKXehM/9IpFjiuQAEwSxsLFPA8TaGjBeE8QBxFmtFhcpREH9xoTAUz05pKiKbD0SlOW3LTniaIp68RKlA1+tOiWuioSOWQC5vq1KdCNapSnSpVq2rVq2I1q1ol6lIzxNWuglWNYR0rbL5K1rPuBK1qzYxZ1+rWH7T1rXIFwAQgoKASQGACc92rTigQgAhIIAASiEAAKMDXw86kAk2tAGIb+xIINNWujp1sSgjLgghQNrMlCSwLJKDZz4LEAgGwAGhLu5ELBOACpl2tRCYQAL2yNrYKwYBsa2vb2+LWrVvdLW9769vfAje4wh0ucYUb1rhqFrnfUS5lmVvK3J7luNC1KVid6/9Y66qyCWr73XbLxAKB2I5F2G2ldB3UggcosgfoZRs5dRCI9q4ivFz86O3gywT5riJaLwVeeR2kq95dw75x6BB+GzFeVtzzkv1tDgGktz2vSM+FLuAmH9z1jD8hgDaHCNMostejEpTRBg0A2fWeh7yxFYAA71MTqaYhFnYdosXfTV41C8mAd2BBCjdmQdaoIA0DfBN8uFBANr9wvLmRRWvdi6dvaLxF2zCgHoN0lwtbyCmAPupJa6swSpuzYPv811MB4Fbf5KEGB+S4xwYuwVvUx2EaFFAHaIaBJO5ATwGkUTRRHoAKKtgyHbyln8/6A7bWbL8ARjBYeBGmyxiNiBT/m2CLBExUAcbWj/rxxS+N/PMN3uyCdR6AaVm4Q83SjNAbQGtYJHCcViQ4LDVD7ctQC3MKiLiHmLlQh5qrQ2Jo4Gksojd/CUBvSr2Crvxlg2aNkOEjGSaWz/TC2Sw04dWAnItDSMHa/1pRsZVxjhjUwWEjTE0Rmd3pJnfjADj828Bwpwl9ufNeQkQYD/uW1q4CZ55FOeOtaWbmZOrgHJ6RS2OKUUSSfMkFRI400NKIQLRl8QZHOwHPbLarYnzUG4meIyOCx+rabREaCK0Dv3sjg3StgUgF/zELRf3vPIjpCxX3WdsWsfFrwqe6sXgY7Rj5xk1NWBn2nq86sBJjY8CZ/ySlCEQ4Vvq8EYJFBBQWGdLn9ra/4SLjk1qbbbDtP0lxW4/fFlrg7GHyUThSvKJ64wWhbJuE/U3qdou33365ZV7aR9YFYvXEDhwdvxcEcwJGEeCZU3i5Hr5402WN3mfNHl0qJUYFXnOW8B3LeQ2+lz6B5Tkgz5r2Sv53PNDl5EGn8zQlaTmch4LnEwp6NU2e9KIfQuKRw5lPgSXLJp5MprwX8iTt+DY2r54gifLjIAc/x1nW8FiEvmLfAw33zI9nL7gQ0kBRWBCa+pMfHQWOGUyhY7bAMfj9JuMcPB2b10s+u6xdzXDCfivfQwBjOH1+diNAemcAu5dPXwRfrZoi5P/ZHQxAszAcyajJFPHAoT1CA9GfzemBpC0aP6za1rQZwWnaG/zZnf1SJVwg0HQeIaEBqc2Z8HXaFxDL1qSDCfmIMJWf0WRLDjQAJ0yRArFP39yZ/kjezY1CYrAZ2VEdmRmLo3VL4/2Ar8jbNkkKHBhUMmlbBrEQDpEKtxnUE/bNX6RLI/mGEc1QEy7Tyc0ByoUgtXxKMPTNQAldovyFI/igDDDPv7zgwlQGyYVDH7hQ/r2h13WbM/wT7DHGMgiAAxCJs4nbG0GbGfaf5S1Jy9Scw52aRUWBknxcunlRQ4AcKGlF31jcwC0AuYmYFmHix/zgz3BRo5zDGbxc6o0M3yT/isWNBawlS4XBwLWsmgziRg02iQ5V1O+NESKggGjE2FY80iiaBb/9wcxtjiIWwdnU3NO9QUasVDJ1Hbe1nTEMYy2s1DSOS/hlQ1aQW9pFI9VtQzdmUBylGDG8Xd+cVLVUXwmEgeZM4/gowqFkHTAIgx5NI9CtVEvNUeCYIMk8BdkUis/dUR/NG+0ZYXtkHifB4+z5AKshxD/0i0LUXnEcHt6dReSIhrIVSUmFX/MEhAMQoUBUJAgtXkIl5EnWUkqq3UJSiEt6hOdh5IDAJNEtQYIVREnuFBGEWH05QXi1XhLAEO7MJIPFQk2KHBNY0gJkkEDVze91EEvaQOYAD1KG/90PBCUSDOU+FOU/dKUQZGUQLGWmOA+j6EnlLVVbbMpdjEAjrQ0XDFmRmVH2LR85zoAadIyUiQOEJdmKcd/z+QldjkqpGEtkiEqPyNiknMDCJFkyJZ8GhUUyPeDHwCVWyGUicAX4XN/w1diWwV/ZDWMcNEA/gpibZFPmaAORsQCn9YdUpl4i6EGiTdoUVJqp9IA8VeDFqU/BXcK/zZkvWoIk6BkHUR5xAgFuZmKgWQRRBuAkHAKxFSApCCep5cENihnjZNvQJB1tWlqr6Un20JnN3Q87uZoOCoBvwuLJWaKj6Y+BcadtIqT/veRHUVuGQQG49QMaUoMa0kAWFpFJ0f9AGc5bIVQZFyID65mburBL0chhDWylKsqhhMHBsTlhHmoQEQHcCAhicZLdHjTGKRLJtNVLHwroDjDAaKqJH4ASC44d5RWhfPbHf0FRi2rLKibMJlZgo1APCqTiInCCI2aR+H3iGjSEjfaN0dRiFChbzWXFF6bcjUjivJ0RwJEKqdGoQwEjiFJj/twcFPWoDXRiPxLNArYTh7oohbgmDrZBIV1p17wDSm1j0TUpxPkjkdyRMzqSOaYdVYrDmzLo35QNqrVAzckY3DijNPKfj/gcwAFkUuKnP2KBlgInBinKERmSS9XpDTClmI2LlmFFm8anMhJH4kzFRAJB6emETpb/VU+JpBCgKkPBqBLNwEEuV5p+ziZ8pXSo6lA1jkO2wqs66RJ8JU4agQBkkCEAqeRk3oMGKyrMyH6tiZvsqmtYhHwFjBKEJe346itBK+2RU+g1wQMkwCUY4Hp9Elwt63JGDrEOgZQgmLTaqrY6QbZeJRKwq7IeYbcmgbhkAiaQZiQWAbOeWirgTX7BK4wyi9At0qIgCfcNEoYZgyVcD/dB3wn8mLaWX8dkyqIMWQ0c5qQ0Jg7o3jvInAipXzVlQpK9APMVoPOtw9XUn7iyQbPcZSyOH495H2KSY5CAIa+Z7C8lWWKK1wp0n15qn4TenYVt7BF1LPRZU5yI6txkoC3o/9sJoSAJzIoBgN+dnUMOQprq0Fs6dAnEwUxudslfUGAm8k/mhAwu9iQM3OKe6SbBxS1x9mC6GKuiNpUkMpq1zO1ZdpgMBtgvxW1WEBsXoUwDoCcfAAmsyOariYml0eai2aA9HWzU7gzK4dA96GfC3BoBGNQp3mGVrCyAVhAQAtRHPiMYAhy+oBCfoZAdRuapic8A9NrqVpiBTsaGGoEVts3t/loX1OG6zksZiiEUJEKJuhvW1ou9PepkGFQfQm1ayqsnDhjK9IaRVm2jgeCYHaCPVMFbTGoBNi7q4pzFWS+ErsEtEoAU+Q9UfqHSoAAnxsBpDGmVhmaR6Jrf0C/yJOHd+pIB8X4CMI4eFJRMjy6vd47UyN0n5T4aRk0vUlXr2aFcsYnNZKyjmqbePhItPvJoen3UOzIwQsVp+h6pItRRFpBDooSj3nRP6RpdpdJI2jWqd3EKoe5sMqzAwamwqKwrSBaq2uXCb6ThPtDN3Rmx+eoRP14u9ZqEA+xXeOXqQywln9IEvZJkvHrERnaLVcKCJbWqTmDxgGixSuZkGZtxKMVqGrMFGrMxQEyrJr2xUVVXcdnxHeNxHuvxHvNxb83xHwNyIAvyIBNyIRvyISNyIivyIjNyIzvyI0NyJGtECAAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     EBV: Epstein-Barr virus; CMV: cytomegalovirus; CBC: complete blood count; ESR: erythrocyte sedimentation rate; CXR: chest radiograph; PPD: purified protein derivative; ANA: antinuclear antibody.",
"     <br>",
"      * Early biopsy is indicated in children with supraclavicular, mediastinal, or massively enlarged nodes or groups of nodes &gt;3 cm.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Toxoplasmosis, histoplasmosis, coccidiomycosis, brucella, rapid plasma reagin (RPR), HIV.",
"       <br>",
"        &Delta; Of the most abnormal node.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Based on information from:",
"     <br>",
"      <ol>",
"       <li>",
"        Soldes OS, Younger JG, Hirschl RB. Predictors of malignancy in childhood peripheral lymphadenopathy. J Pediatr Surg 1999; 34:1447.",
"       </li>",
"       <li>",
"        Slap GB, Brooks JS, Schwartz JS. When to perform biopsies of enlarged peripheral lymph nodes in young patients. JAMA 1984; 252:1321.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39710=[""].join("\n");
var outline_f38_49_39710=null;
var title_f38_49_39711="Normal fifth metatarsal apophysis";
var content_f38_49_39711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F56985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F56985&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Apophysis of the fifth metatarsal",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 229px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Orientation of the apophysis of the fifth metatarsal is parallel to the shaft and should not be confused with a fracture. (This patient also has an undisplaced, transverse fracture.)",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jarvis JG, Moroz PJ. Fractures and Dislocations of the Foot. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_49_39711=[""].join("\n");
var outline_f38_49_39711=null;
